<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">97179</article-id>
<article-id pub-id-type="doi">10.7554/eLife.97179</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.97179.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The GnRH pulse generator activity in mouse models of polycystic ovary syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Ziyue</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Su Young</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pardo-Navarro</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wall</surname>
<given-names>Ellen G</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Desai</surname>
<given-names>Reena</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vas</surname>
<given-names>Szilvia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Handelsman</surname>
<given-names>David J</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Herbison</surname>
<given-names>Allan E</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Physiology, Development and Neuroscience, University of Cambridge</institution>, Cambridge CB2 3EG, <country>United Kingdom</country></aff>
<aff id="a2"><label>2</label><institution>ANZAC Research Institute, University of Sydney</institution>, Sydney, <country>Australia</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Yan</surname>
<given-names>Wei</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Washington State University</institution>
</institution-wrap>
<city>Pullman</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Yan</surname>
<given-names>Wei</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Washington State University</institution>
</institution-wrap>
<city>Pullman</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence should be addressed to Allan E. Herbison (Email: <email>aeh36@cam.ac.uk</email>)</corresp>
<fn id="n1"><p><italic>Disclosures</italic>: The authors have nothing to disclose and no competing interests.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-08-13">
<day>13</day>
<month>08</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP97179</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-05-12">
<day>12</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-06-06">
<day>06</day>
<month>06</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.06.04.597387"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Zhou et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhou et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-97179-v1.pdf"/>
<abstract>
<title>Abstract</title><p>One in five women worldwide suffer from polycystic ovary syndrome (PCOS) that, alongside subfertility and hyperandrogenism, typically presents with increased luteinizing hormone (LH) pulsatility. As such, it is suspected that the arcuate kisspeptin (ARN<sup>KISS</sup>) neurons that represent the GnRH pulse generator are dysfunctional in PCOS. We used here <italic>in vivo</italic> GCaMP fiber photometry and other approaches to examine the behavior of the GnRH pulse generator in two mouse models of PCOS. We began with the peripubertal androgen (PPA) mouse model of PCOS but found that it had a reduction in the frequency of ARN<sup>KISS</sup> neuron synchronization events (SEs) that drive LH pulses. Examining the prenatal androgen (PNA) model of PCOS, we observed highly variable patterns of pulse generator activity with no significant differences detected in ARN<sup>KISS</sup> neuron SEs, pulsatile LH secretion, or serum testosterone, estradiol, and progesterone concentrations. However, an unsupervised machine learning approach identified that the ARN<sup>KISS</sup> neurons of acyclic PNA mice continued to exhibit cyclical patterns of activity similar to that of normal mice. The frequency of ARN<sup>KISS</sup> neuron SEs was significantly increased in algorithm-identified “diestrous stage” PNA mice compared to controls. In addition, ARN<sup>KISS</sup> neurons exhibited reduced feedback suppression to progesterone in PNA mice and their pituitary gonadotrophs were also less sensitive to GnRH. These observations demonstrate the importance of understanding GnRH pulse generator activity in mouse models of PCOS. The unexpected functional disassociation of cyclical GnRH pulse generator activity in the acyclic PNA mouse indicates the presence of a complex phenotype with deficits at multiple levels of the hypothalamo-pituitary-gonadal axis.</p>
</abstract>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Polycystic ovary syndrome (PCOS) is one of the most common causes of female infertility with variable reproductive and metabolic phenotypes (<xref ref-type="bibr" rid="c6">Bozdag, Mumusoglu et al. 2016</xref>, <xref ref-type="bibr" rid="c35">Lizneva, Suturina et al. 2016</xref>). Many women with PCOS have an elevated body mass index but up to 30% of patients do not, resulting in PCOS being further classified into obese and lean subtypes (<xref ref-type="bibr" rid="c47">Nestler and Jakubowicz 1997</xref>, <xref ref-type="bibr" rid="c30">Kumari, Haq et al. 2005</xref>, <xref ref-type="bibr" rid="c66">Toosy, Sodi et al. 2018</xref>). Although androgen excess, oligo-menorrhea/anovulation, and the existence of polycystic ovaries are the key diagnostic indicators for PCOS, a common secondary feature is increased luteinizing hormone (LH) pulsatility (<xref ref-type="bibr" rid="c69">Waldstreicher, Santoro et al. 1988</xref>, <xref ref-type="bibr" rid="c65">The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group 2004</xref>). Basal and pulsatile LH secretion can be up to threefold higher in both lean and obese PCOS women and is considered to be a significant contributor to their subfertility (<xref ref-type="bibr" rid="c43">Morales, Laughlin et al. 1996</xref>, <xref ref-type="bibr" rid="c15">Dam, Roelfsema et al. 2002</xref>, <xref ref-type="bibr" rid="c51">Phylactou, Clarke et al. 2021</xref>). A presumed increase in the frequency of pulsatile gonadotropin-releasing hormone (GnRH) secretion in PCOS women results in an increased LH/follicle-stimulating hormone (FSH) ratio (<xref ref-type="bibr" rid="c75">Wildt, Häusler et al. 1981</xref>, <xref ref-type="bibr" rid="c14">Dalkin, Haisenleder et al. 1989</xref>). This is thought to drive excess ovarian androgen production that, in turn, impairs estrogen and progesterone feedback regulation of GnRH secretion (<xref ref-type="bibr" rid="c49">Pastor, Griffin-Korf et al. 1998</xref>, <xref ref-type="bibr" rid="c9">Chhabra, McCartney et al. 2005</xref>, <xref ref-type="bibr" rid="c41">Moore, Prescott et al. 2013</xref>, <xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>).</p>
<p>It has become clear that the arcuate nucleus kisspeptin (ARN<sup>KISS</sup>) neurons represent the mammalian GnRH pulse generator (<xref ref-type="bibr" rid="c10">Clarkson, Han et al. 2017</xref>, <xref ref-type="bibr" rid="c26">Herbison 2018</xref>, <xref ref-type="bibr" rid="c18">Goodman, Herbison et al. 2022</xref>). These neurons exhibit brief episodes of synchronized activity that release kisspeptin on the distal projections of GnRH neurons to drive pulsatile GnRH secretion into the portal vasculature (<xref ref-type="bibr" rid="c27">Herbison 2021</xref>, <xref ref-type="bibr" rid="c34">Liu, Yeo et al. 2021</xref>). Recent studies indicate that the synchronized activity amongst ARN<sup>KISS</sup> neurons required for pulsatile hormone secretion is generated by local glutamatergic transmission that is subsequently modulated by neurokinin B and dynorphin (<xref ref-type="bibr" rid="c53">Qiu, Nestor et al. 2016</xref>, <xref ref-type="bibr" rid="c22">Han, Morris et al. 2023</xref>, <xref ref-type="bibr" rid="c45">Morris and Herbison 2023</xref>). While the ARN<sup>KISS</sup> neurons are the primary site of estrogen negative feedback suppressing pulsatile GnRH secretion (<xref ref-type="bibr" rid="c38">McQuillan, Clarkson et al. 2022</xref>), the mechanism of progesterone feedback remains unclear but could also involve the ARN<sup>KISS</sup> neurons (<xref ref-type="bibr" rid="c19">Goodman, Holaskova et al. 2011</xref>). As such, it is thought that dysfunction within the ARN<sup>KISS</sup> neuron pulse generator may be responsible for the elevated LH pulse frequency observed in PCOS (<xref ref-type="bibr" rid="c71">Walters, Gilchrist et al. 2018</xref>, <xref ref-type="bibr" rid="c11">Coutinho and Kauffman 2019</xref>, <xref ref-type="bibr" rid="c55">Rodriguez Paris and Bertoldo 2019</xref>, <xref ref-type="bibr" rid="c57">Ruddenklau and Campbell 2019</xref>).</p>
<p>We have developed GCaMP fiber photometry methodologies that allow the activity of the ARN<sup>KISS</sup> neuron pulse generator to be monitored at high temporal resolution in freely behaving mice (<xref ref-type="bibr" rid="c21">Han, Kane et al. 2019</xref>, <xref ref-type="bibr" rid="c21">McQuillan, Han et al. 2019</xref>, <xref ref-type="bibr" rid="c68">Vas, Wall et al. 2024</xref>). Using this and other approaches, we report here a detailed investigation into the pulse generator activity in two widely used mouse models of PCOS including the peripubertal androgen (PPA) model of “obese PCOS”, and prenatal androgen (PNA) model of “lean PCOS” (<xref ref-type="bibr" rid="c61">Stener-Victorin, Padmanabhan et al. 2020</xref>).</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Peripubertal androgen (PPA) mice</title>
<sec id="s2a1">
<label>1.</label><title>Peripubertal dihydrotestosterone (DHT)-treated animals exhibit significantly increased body weight with acyclic estrous cycles</title>
<p>Female 129S6Sv/Ev C57BL/6 <italic>Kiss1<sup>Cre/+</sup></italic>,GCaMP6s mice exposed to DHT from 3 weeks of age (PPA: n=4) started to show a significant increase in weight 4 weeks after capsule implantation compared to controls with empty capsules (control: n=5) (Sidak’s multiple comparisons test; <xref rid="fig1" ref-type="fig">Fig.1</xref>-Suppl. Fig.1A). The PPA animals were completely acyclic with vaginal cytology only ever showing the diestrous stage (<xref rid="fig1" ref-type="fig">Fig.1</xref>-Suppl. Fig.1B-D).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Slower pulse generator activity in PPA animals.</title><p>Representative 24-hour photometry recordings showing synchronization events (SEs) observed in diestrous (<bold>A</bold>) control and (<bold>B</bold>) PPA females with the light-off period (19:00-07:00) represented by the shaded area and expanded views of the traces (13:00-17:00) from (A-B). Triangles point to identified SEs. (<bold>C</bold>) SE frequency and (<bold>D</bold>) SE intervals in control (n=5) and PPA (n=4) mice. Mann-Whitney U tests. (<bold>E</bold>) Frequency histograms showing relative SE frequencies occurring in 20-minute bins, calculated separately for controls (white, n=114, 5 mice) and PPA (orange, n=55, 4 mice). X-axis represents the bin centers. (<bold>F</bold>) Continuous recordings at 10 Hz sampling rate showing normalized profile of SE overlaid from control (black, 7 SEs from 5 animals) and PPA (orange, 5 SEs from 4 animals). ‘a’ and ‘b’ give values of full width at half maximum (FWHM) upswing and downswing respectively. (<bold>G</bold>) FWHM length of control (n=5) and PPA (n=4) animals. Mann-Whitney U test. (<bold>H</bold>) Durations of upswing and downswing for control (n=5) and PPA (n=4) animals, respectively. Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Data show mean ± SEM. Each circle is an individual animal. * <italic>P</italic> &lt; 0.05</p></caption>
<graphic xlink:href="597387v1_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2a2">
<label>2.</label><title>Peripubertal exposure to DHT results in a slowed GnRH pulse generator</title>
<p>Abrupt and large increases in arcuate nucleus kisspeptin (ARN<sup>KISS</sup>) neurons activity, termed synchronization events (SEs), are observed with GCaMP fiber photometry in mice (<xref ref-type="bibr" rid="c10">Clarkson, Han et al. 2017</xref>, <xref ref-type="bibr" rid="c21">Han, Kane et al. 2019</xref>, <xref ref-type="bibr" rid="c39">McQuillan, Han et al. 2019</xref>). Both adult PPA and control mice recorded in diestrus for 24 hours exhibited ARN<sup>KISS</sup> neuron SEs (<xref rid="fig1" ref-type="fig">Fig.1A,B</xref>). The frequency of SEs in PPA mice (n=4) was approximately half that of controls (n=5) with SE frequency/hour showing an inhibitory trend (<italic>P</italic> = 0.0714, Mann-Whitney U test; <xref rid="fig1" ref-type="fig">Fig.1C</xref>) and SE interval significantly increased (<italic>P</italic> = 0.0159, Mann-Whitney U test; <xref rid="fig1" ref-type="fig">Fig.1D</xref>). The SE interval frequency distribution pattern revealed a shift to the right for PPA mice with a tight clustering within the 70-90-minute bin centers (<xref rid="fig1" ref-type="fig">Fig.1E</xref>). To compare the dynamics of SEs from control and PPA animals, continuous (10 Hz) photometry recordings were performed in diestrus to obtain high temporal resolution profiles (<xref rid="fig1" ref-type="fig">Fig.1F</xref>). These profiles were the same between control (n=5) and PPA (n=4) animals with SE duration, and both upswing and downswing durations calculated from the full-width half maximum (FWHM) points being not significantly different (<xref rid="fig1" ref-type="fig">Fig.1G-H</xref>).</p>
</sec>
</sec>
<sec id="s2b">
<title>Prenatal androgen (PNA) mice</title>
<sec id="s2b1">
<label>1.</label><title>The PNA mouse model exhibits highly disordered estrous cyclicity</title>
<p>Female mice originating from dams treated with DHT on gestational days 16, 17, and 18 were found to have a significantly increased anogenital distance (n=10; <italic>P</italic> &lt; 0.001, Mann-Whitney U test) compared with controls (n=9; <xref rid="fig2" ref-type="fig">Fig.2A</xref>). Body weight was not different between PNA and control animals at 10 weeks of age (n=12 per group; <italic>P</italic> = 0.6602, Mann-Whitney U test; <xref rid="fig2" ref-type="fig">Fig.2B</xref>). The PNA mice exhibited very disordered estrous cycles remaining mostly in persistent diestrus (71 ± 3%) with occasional excursions to metestrus. The proestrus stage was never encountered and estrus was observed rarely (<xref rid="fig2" ref-type="fig">Fig.2C-E</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Prenatal androgen exposure leads to increased anogenital distance and disrupted estrous cyclicity.</title>
<p>(<bold>A</bold>) Anogenital distance (control: n=9; PNA: n=10) and (<bold>B</bold>) Body weight of control and PNA animals (n=12 per group). Mann-Whitney U tests. (<bold>C</bold>) Proportion of time spent at each estrous cycle stage over 21 days (n=7 per group). Two-way ANOVA followed by Sidak’s post-hoc tests. (<bold>D-E</bold>) Representative graphs of estrous cycle pattern in (<bold>D</bold>) control and (<bold>E</bold>) PNA females. P, proestrus; E, estrus; M, metestrus; D, diestrus. (<bold>F</bold>) Serum testosterone level of control (n=13) and PNA (n=20) animals in diestrus measured by enzyme-linked immunosorbent assay (ELISA). The limit of detection for testosterone ELISA is 0.066 ng/mL. (<bold>G-I</bold>) Plasma levels of (<bold>G</bold>) androstenedione, (<bold>H</bold>) estradiol, and (<bold>I</bold>) progesterone in control and PNA animals measured using liquid chromatography-mass spectrometry (LC-MS). Blood samples were collected at 10:00 diestrus (n=6 per group). Dotted lines represent the limit of detection for each hormone. Androstenedione: 0.05 ng/mL; estradiol: 0.50 pg/mL; progesterone: 0.05 ng/mL. All samples were below limit of detection for testosterone LC-MS measurement (&lt; 0.01 ng/mL). Mann-Whitney U tests. Data show mean ± SEM. Each circle is an individual animal. ** P &lt; 0.01, *** P &lt; 0.001.</p></caption>
<graphic xlink:href="597387v1_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2b2">
<label>2.</label><title>Circulating gonadal steroid hormone levels are not different between control and PNA animals</title>
<p>As androgen excess is one of the hallmarks of PCOS, we initially measured serum testosterone levels in control and PNA animals using a commercial testosterone enzyme-linked immunosorbent assay (ELISA) (<xref ref-type="bibr" rid="c54">Risal, Manti et al. 2021</xref>). This did not detect any difference in serum testosterone levels between control (n=13) and PNA (n=20) animals in diestrus (<italic>P</italic> = 0.8203, Mann-Whitney U test; <xref rid="fig2" ref-type="fig">Fig.2F</xref>). Given concerns over the sensitivity and specificity of the steroid hormone ELISAs (<xref ref-type="bibr" rid="c24">Handelsman, Jimenez et al. 2015</xref>), we progressed to using ultrasensitive liquid chromatography-mass spectrometry (LC-MS) (<xref ref-type="bibr" rid="c23">Handelsman, Gibson et al. 2020</xref>) to measure the circulating levels of testosterone, androstenedione, estradiol, and progesterone in diestrous PNA and control mice (n=6 per group). No significant differences (Mann-Whitney U tests) were detected for androstenedione, estradiol, or progesterone while all samples were below the limit of detection for testosterone (&lt; 0.01 ng/mL) (<xref rid="fig2" ref-type="fig">Fig.2G-I</xref>).</p>
</sec>
<sec id="s2b3">
<label>3.</label><title>Kisspeptin, neurokinin B, and dynorphin immunoreactivity are relatively unchanged within the ARN of PNA mice</title>
<p>Previous studies have found variable effects of PNA treatment on kisspeptin, neurokinin B (NKB), and dynorphin protein and mRNA expression within the ARN (Barnes, Rosenfield et al., <xref ref-type="bibr" rid="c77">Yan, Yuan et al. 2014</xref>, <xref ref-type="bibr" rid="c48">Osuka, Iwase et al. 2016</xref>, <xref ref-type="bibr" rid="c17">Gibson, Jaime et al. 2021</xref>, <xref ref-type="bibr" rid="c36">McCarthy, Dischino et al. 2021</xref>, <xref ref-type="bibr" rid="c40">Moore, Lohr et al. 2021</xref>). To re-examine this issue, we assessed levels of immunofluorescence for all three peptides in the ARN of control (n=4-8) and PNA (n=4-6) mice (<xref rid="fig2" ref-type="fig">Fig.2</xref>-Suppl. Fig.1A-C). This revealed a significant but modest elevation in kisspeptin immunofluorescence within the rostral ARN (<italic>P</italic> = 0.0187, Sidak’s multiple comparisons test) in PNA mice but not elsewhere in the ARN (<xref rid="fig2" ref-type="fig">Fig.2</xref>-Suppl. Fig.1A). No significant changes were detected for NKB or dynorphin immunoreactivity in any region of the ARN (<xref rid="fig2" ref-type="fig">Fig.2</xref>-Suppl. Fig.1B,C).</p>
</sec>
<sec id="s2b4">
<label>4.</label><title>PNA animals exhibit highly variable patterns of ARN<sup>KISS</sup> neuron SEs</title>
<p>Both control and PNA mice exhibited robust SEs across 24-hour recording periods (<xref rid="fig3" ref-type="fig">Fig.3A-D</xref>). Control mice recorded in diestrus had approximately 0.8 SEs per hour (<xref rid="fig3" ref-type="fig">Fig.3E</xref>) with an SE interval of 74.75 ± 5.71 min (<xref rid="fig3" ref-type="fig">Fig.3F</xref>) and a normal-like distribution of SE intervals (<xref rid="fig3" ref-type="fig">Fig.3G</xref>). Unexpectedly, diestrous PNA mice exhibited highly variable patterns of ARN<sup>KISS</sup> neuron activity that could appear similar to diestrous controls (<xref rid="fig3" ref-type="fig">Fig.3C</xref>) or very different (<xref rid="fig3" ref-type="fig">Fig.3D</xref>) with episodes of multi-peak SEs (mpSEs). However, overall SE frequency and intervals were not different between PNA (n=6) and control (n=7) animals (<xref rid="fig3" ref-type="fig">Fig.3E,F</xref>; Mann-Whitney U tests). The frequency distribution of inter-SE intervals in PNA mice exhibited a peak interval cluster around the 10-minute bin center (39%) with a gradual tail off in SE intervals (<xref rid="fig3" ref-type="fig">Fig.3G</xref>). Continuous (10 Hz) photometry recordings in diestrus did not reveal any difference in the profiles of single SEs between controls (n=7) and PNA (n=6) animals (<xref rid="fig3" ref-type="fig">Fig.3H-J</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>PNA animals exhibit highly variable patterns of ARN<sup>KISS</sup> neuron SEs</title><p>Representative 24-hour photometry recordings showing SEs observed in (<bold>A,B</bold>) two control and (<bold>C,D</bold>) two PNA females with the light-off period (17:30-05:30 or 19:00-07:00) represented by the shaded area. Recordings were performed when vaginal cytology indicated diestrus. (<bold>E</bold>) SE frequency and (<bold>F</bold>) SE intervals in control (n=7) and PNA (n=6) mice. Mann-Whitney U tests. (<bold>G</bold>) Frequency histograms showing relative SE frequencies occurring in 20-minute bins, calculated separately for controls (black, n=123, 7 mice) and PNA (red, n=98, 6 mice). X-axis represents the bin centers. Multi-peak SE (mpSE) with peaks occurring within 160 seconds was considered as one SE with interval calculated from the first peak. (<bold>H</bold>) Continuous (10 Hz) recording showing normalized mean profile of SE overlaid from control (black, 22 SEs from 7 animals) and PNA (red, 20 SEs from 6 animals). <bold>(I)</bold> FWHM length (upswing + downswing) in control (n=7) and PNA (n=6) animals. Mann-Whitney U test. (<bold>J</bold>) Durations of FWHM upswing and downswing for control (n=7) and PNA (n=6) animals, respectively. Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Data show mean ± SEM. Each circle is an individual animal.</p></caption>
<graphic xlink:href="597387v1_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2b5">
<label>5.</label><title>PNA mice have elevated mean LH secretion but normal LH pulse frequency</title>
<p>We have previously found a near perfect relationship between ARN<sup>KISS</sup> neuron SEs and pulsatile LH secretion in male and female mice (<xref ref-type="bibr" rid="c21">Han, Kane et al. 2019</xref>, <xref ref-type="bibr" rid="c39">McQuillan, Han et al. 2019</xref>). To assess this relationship in PNA mice, ARN<sup>KISS</sup> neuron recordings were commenced, and tail-tip blood samples taken at 12-minute intervals until an SE was detected after which the blood sampling rate was switched to 6-minute intervals. We observed a perfect correlation between SEs and pulsatile LH secretions in both control and PNA mice: every SE was followed by an LH pulse, and no LH pulses were detected without a preceding SE (<xref rid="fig4" ref-type="fig">Fig.4A,C</xref>). Temporal analysis of SEs and LH release indicated that the SE peak precedes each LH peak by 7.7 ± 0.6 minutes and 6.6 ± 0.4 minutes in control (n=7 from 4 mice) and PNA (n=7 from 5 mice) animals (<italic>P</italic> = 0.190, Mann-Whitney U test), respectively (<xref rid="fig4" ref-type="fig">Fig.4B,D</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Increased total LH concentration but normal LH pulse frequency in PNA animals.</title><p>Representative examples from (<bold>A</bold>) control and (<bold>C</bold>) PNA mice showing the relationship of SEs (black) with LH secretions (red). Triangles and red asterisks indicate identified SEs and LH pulses, respectively. Normalized increase in LH plotted against the SEs in (<bold>B</bold>) control and (<bold>D</bold>) PNA animals. The amplitudes of SEs and serum LH levels were normalized to their peaks, with time 0 being the peak of LH in control (n=7 from 4 mice) and PNA (n=7 from 5 mice) animals. Representative examples of LH pulse profiles in (<bold>E</bold>) control and (<bold>F</bold>) PNA animals. Red asterisks indicate identified LH pulses. (<bold>G</bold>) Total LH concentration, (<bold>H</bold>) LH pulse frequency per hour, and (<bold>I</bold>) LH pulse amplitude in diestrous control (n=7, with 13 LH pulses) and PNA (n=8, with 21 LH pulses) mice during 4-hour sampling at 10-minute intervals. Mann-Whitney U tests. (<bold>J</bold>) Change in LH levels following an intraperitoneal injection of GnRH (200 ng/kg, i.p.) in diestrous control (n=7) and PNA (n=11) mice. An asterisk above the 20 minutes data point denote significance between LH levels in control and PNA from two-way repeated-measure ANOVA followed by Sidak’s post-hoc tests. (<bold>K</bold>) GnRH-evoked changes in LH levels in control (n=7) and PNA (n=11) mice were calculated by the difference in LH levels before (-10 minutes and 0 minutes) and after (10 minutes and 20 minutes) GnRH injections. Mann-Whitney U test. Data show mean ± SEM. Each circle is an individual animal. * <italic>P</italic> &lt; 0.05, ** <italic>P</italic> &lt; 0.01</p></caption>
<graphic xlink:href="597387v1_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The absence of significant differences in ARN<sup>KISS</sup> neuron SE frequency in PNA mice and their tight correlation with pulsatile LH secretion indicated that pulsatile LH secretion may not be different between PNA and control mice. Prior studies have found conflicting data with one finding no difference in LH pulse frequency (<xref ref-type="bibr" rid="c36">McCarthy, Dischino et al. 2021</xref>) and another reporting increased LH pulsatility (<xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>). To re-address this we undertook 4-hour tail-tip blood sampling at 10-minute intervals to assess pulsatile LH secretion in wild-type C57BL6/J diestrous-stage PNA (n=8) and control (n=7) mice. Mean LH levels were found to be significantly elevated in PNA mice (<italic>P</italic> = 0.0205, Mann-Whitney U test; <xref rid="fig4" ref-type="fig">Fig.4E-G</xref>) but the variable LH pulse frequency and amplitude were unchanged compared to controls (<xref rid="fig4" ref-type="fig">Fig.4H,I</xref>).</p>
<p>To evaluate whether the response of pituitary gonadotrophs to GnRH was altered, PNA and control mice were given GnRH (200 ng/kg, i.p.) at the end of the 4-hour tail-tip bleeding, and two further tail-tip blood samples collected for LH measurement at 10-minute intervals. Both control (n=7) and PNA (n=11) mice showed elevated LH levels in response to exogenous GnRH (<xref rid="fig4" ref-type="fig">Fig.4J</xref>). However, PNA mice showed a small but significantly lower level of LH 20 minutes after GnRH injection (P=0.0152, Sidak’s multiple comparisons test). The total GnRH-evoked increment in LH release was significantly lower in PNA mice compared to controls (<italic>P</italic> = 0.0028, Mann-Whitney U test, <xref rid="fig4" ref-type="fig">Fig.4K</xref>).</p>
</sec>
<sec id="s2b6">
<label>6.</label><title>The pulse generator exhibits cyclical activity in PNA mice</title>
<p>The patterns of ARN<sup>KISS</sup> neuron SEs recorded from acyclic “diestrous” PNA mice were highly variable and could exhibit typical diestrous-like activity but also characteristics such as mpSEs (<xref rid="fig3" ref-type="fig">Fig.3D</xref>) that are only usually observed during estrus and metestrus (<xref ref-type="bibr" rid="c68">Vas, Wall et al. 2024</xref>). This suggested that, despite the acyclical state of the PNA mice, the pulse generator may still be undergoing cycles of activity. To assess this, we conducted long-duration photometry recordings in both PNA and control mice for four consecutive days starting on proestrus for controls and any day for the acyclic PNA mice. We have recently found that k-means clustering, an unsupervised machine learning-based approach, provides a very sensitive characterization of ARN<sup>KISS</sup> neuron activity across the estrous cycle (<xref ref-type="bibr" rid="c68">Vas, Wall et al. 2024</xref>). This involves analysis of SEs based on five parameters: the frequency of regular single-peak SEs; the standard deviation of inter-SE intervals for regular SEs; and the number, duration, and profiles of mpSEs (<xref rid="fig5" ref-type="fig">Fig.5A</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>PNA animals exhibit cycling pulse generator activity.</title><p>(<bold>A</bold>). Cluster centroid values for normalized parameters used in k-means clustering with a schematic plot of corresponding photometry recordings patterns. The parameters used for cluster assignments are labelled in Cluster_0 with the following axes: (top) standard deviation (SD) of SE intervals, (top right) number of multi-peak SEs (mpSEs), (bottom right) number of single SEs, (bottom left) number of peaks in mpSEs, (top left) duration of mpSEs. All axes have a minimum value of 0 and maximum value of 1. (<bold>B</bold>) Bar graph indicating proportion of the cluster-assignments for 4-day recordings in control (n=5) and PNA (n=4) animals. Data show mean ± SEM. (<bold>C-D</bold>) Representative examples of four-day consecutive recording of ARN<sup>KISS</sup> activity and corresponding hourly k-means cluster assignments in (<bold>C</bold>) two control animals starting in proestrus on day 1 and transiting to diestrus on day 4 according to vaginal smears; (<bold>D</bold>) two PNA animals remaining in either metestrus or diestrus for four days. Light-off periods (19:00-07:00) are represented by the shaded area in the photometry recording. Color fields represent the assigned clusters for the center (4<sup>th</sup> hour) of the 7-hour moving time windows. Estrous stages of the mice determined by vaginal lavage at the beginning and the end of each 24-hour recording were labelled above the corresponding k-means cluster assignments: proestrus to estrus (PE), estrus to metestrus (EM), metestrus to diestrus (MD), stuck in metestrus (MM), or stuck in diestrus (DD). K-means clustering was performed without vaginal cytology information.</p></caption>
<graphic xlink:href="597387v1_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>All control animals showed typical cycling patterns of ARN<sup>KISS</sup> neuron activity over the four-day recording period (n=5, two representative examples shown in <xref rid="fig5" ref-type="fig">Fig.5C</xref>). The most pronounced features of this cyclicity are the suppression of all SE activity during late proestrus to early estrus (represented by Cluster_0 activity) with a gradual return in SEs during the late estrus (Cluster_1). This is often followed by the appearance of mpSEs (Cluster_3/4) during the estrus to metestrus transition. The activity patterns then become the typical diestrous single SEs with variable frequencies (Cluster_1 &amp; _2) (<xref rid="fig5" ref-type="fig">Fig.5C</xref>). Surprisingly, we observed that the ARN<sup>KISS</sup> neurons in PNA mice also exhibited variable but shifting SE profiles over the four-day recordings despite vaginal smears remaining in metestrus or diestrus throughout (n=4, two examples shown in <xref rid="fig5" ref-type="fig">Fig.5D</xref>). These PNA mice exhibited a cyclical pattern of activity similar to that of control mice with a period of slow Cluster_0 activity directly followed by an mpSEs period (Cluster_3/4) and then regular diestrous activity (Cluster_1 &amp; _2) (<xref rid="fig5" ref-type="fig">Fig.5D</xref>).</p>
<p>Overall, quantification of the time spent in each cluster pattern over the four days was remarkably similar between control (n=5) and PNA (n=4) mice (<xref rid="fig5" ref-type="fig">Fig.5B</xref>). The proportion of Cluster_0 (PNA 21%; control 21%) and Cluster_1 (PNA 44%; control 42%) activity was almost identical with the major trend being a nonsignificant increased time (<italic>P</italic> &gt; 0.05, Sidak’s multiple comparisons test) spent in mpSE Cluster_3/4 activity (PNA 20%; control 12%) at the expense of the fast regular SE Cluster_2 pattern (PNA 15%; control 25%) (<xref rid="fig5" ref-type="fig">Fig.5B</xref>).</p>
</sec>
<sec id="s2b7">
<label>7.</label><title>PNA mice have increased diestrous-like GnRH pulse generator frequency</title>
<p>Given that our earlier recordings from PNA mice (<xref rid="fig3" ref-type="fig">Fig.3C,D</xref>) were unavoidably taken from random times of the pulse generator cycle, we used the unsupervised machine learning algorithm above to identify “diestrous-like” (Cluster_1&amp;_2) episodes of ARN<sup>KISS</sup> neuron SE activity in PNA mice and compared this with diestrous controls. In this case, the frequency of SEs was 48% greater in PNA mice (n=6) compared to control animals (n=7; <italic>P</italic> = 0.0029, Mann-Whitney U test; <xref rid="fig6" ref-type="fig">Fig.6C</xref>) as also reflected in a significantly lower inter-SE interval (<italic>P</italic> = 0.0047, Mann-Whitney U test; <xref rid="fig6" ref-type="fig">Fig.6D</xref>). The frequency distribution of inter-SE intervals in PNA mice was slightly shifted to the left compared to control mice so that majority of PNA SE intervals were in 10-70 minute bin compared to the 30-90 minute bin centers in control mice (<xref rid="fig6" ref-type="fig">Fig.6E</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Faster ARN<sup>KISS</sup> neuron synchronization events in “diestrous-like” PNA animals.</title><p>Representative 24-hour photometry recordings showing ARN<sup>KISS</sup> neuron SEs observed in (<bold>A</bold>) diestrous control and (<bold>B</bold>) algorithm-identified diestrous PNA females. The light-off period (17:30-05:30) is represented by the shaded area. (<bold>C</bold>) SE frequency and (<bold>D</bold>) SE intervals in control (n=7) and PNA (n=6) mice. Mann-Whitney U tests. (<bold>E</bold>) Histogram showing percentage of SE interval frequencies occurring in 20-minute bins, calculated separately for controls (black, n=119, 7 mice) and PNA (red, n=151, 6 mice) animals. X-axis represents the bin centers.</p></caption>
<graphic xlink:href="597387v1_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2b8">
<label>8.</label><title>PNA mice have impaired progesterone negative feedback</title>
<p>Progesterone negative feedback is thought to be abnormal in women with PCOS (<xref ref-type="bibr" rid="c49">Pastor, Griffin-Korf et al. 1998</xref>, <xref ref-type="bibr" rid="c9">Chhabra, McCartney et al. 2005</xref>) and PNA mice (<xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>). We assessed the response of ARN<sup>KISS</sup> neuron activity to vehicle or progesterone (4 mg/kg, i.p.) in PNA and control mice with diestrous activity patterns. As expected (<xref ref-type="bibr" rid="c39">McQuillan, Han et al. 2019</xref>), we found a marked suppression of ARN<sup>KISS</sup> neuron SEs that lasted for up to 6 hours following progesterone in control mice (n=3, <italic>P</italic> &lt; 0.001, Sidak’s multiple comparisons test, <xref rid="fig7" ref-type="fig">Fig.7A,B,E</xref>). The response in PNA mice was much less consistent, and overall, no significant differences in SE activity detected at any time point (n=3, <xref rid="fig7" ref-type="fig">Fig.7C,D,F</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Defective progesterone negative feedback in PNA animals.</title><p>(<bold>A-D</bold>) Examples of 15-hour photometry recordings of the pulse generator activity in (<bold>A-B</bold>) control and (<bold>C-D</bold>) PNA animals receiving (<bold>A</bold>,<bold>C</bold>) vehicle (Veh) or (<bold>B</bold>,<bold>D</bold>) progesterone (P4, 4 mg/kg) i.p. injections. Dashed line represents when i.p. injection took place. Normalized number of SEs in (<bold>E</bold>) control (n=3) and (<bold>F</bold>) PNA (n=3) animals before and after vehicle (black) and P4 (red) injections. Data were analyzed in 3-hour bins and normalized to the number of SEs before injections (-3-0 h) for each mouse. The asterisks above the data point denote significant effects at indicated time periods compared to the pre-treatment period (-3-0 h) by Sidak’s multiple comparisons test. Data represent mean ± SEM. Two-way repeated-measure ANOVA with Sidak’s multiple comparisons tests. *** <italic>P</italic> &lt; 0.001.</p></caption>
<graphic xlink:href="597387v1_fig7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2b9">
<label>9.</label><title>No differences exist in ARN<sup>KISS</sup> neuron activity in ovariectomized (OVX) PNA and control females</title>
<p>Gonadal steroids play a key role in modulating the activity of the ARN<sup>KISS</sup> neurons (<xref ref-type="bibr" rid="c39">McQuillan, Han et al. 2019</xref>, <xref ref-type="bibr" rid="c38">McQuillan, Clarkson et al. 2022</xref>). To assess whether any differences exist in ARN<sup>KISS</sup> neuron activity in PNA mice in the absence of gonadal steroids, we undertook 24-hour fiber photometry recordings in mice that had been ovariectomized for at least 3 weeks. Removal of gonadal steroids results in increased SE frequency and the emergence of clusters of tightly coupled individual synchronizations as previously described (<xref ref-type="bibr" rid="c37">McQuillan, Clarkson et al. 2022</xref>) (<xref rid="fig8" ref-type="fig">Fig.8A,B</xref>). We observed no significant differences (Mann-Whitney U tests) between SE frequency (<xref rid="fig8" ref-type="fig">Fig. 8C</xref>) or intervals (<xref rid="fig8" ref-type="fig">Fig. 8D,E</xref>) in PNA and control animals (n=4 per group). Similarly, high-resolution recordings at 10 Hz did not reveal any differences in SE profiles between OVX control and OVX PNA mice (<xref rid="fig8" ref-type="fig">Fig.8F,H</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Similar ARN<sup>KISS</sup> activity and SE profiles in control and PNA animals following ovariectomy.</title><p>Representative 24-hour photometry recordings showing ARN<sup>KISS</sup> neuron SEs observed in (<bold>A</bold>) control and (<bold>B</bold>) PNA females 3 weeks after ovariectomy (OVX) with the light-off period (19:00-07:00) represented by the shaded area and expanded views of the traces (13:00-15:00) from (A-B). (<bold>C</bold>) SE frequency and (<bold>D</bold>) SE intervals in control and PNA mice (n=4), Mann-Whitney U tests. (<bold>E</bold>) Histogram showing relative SE frequencies occurring in 5-minute bins, calculated separately for controls (n=212, 4 mice) and PNA (n=233, 4 mice) animals. X-axis represents the bin centers. Each SE cluster was analyzed as a single SE with the interval calculated from the first peak. (<bold>F</bold>) Continuous recordings at 10 Hz sampling rate showing normalized profile of SEs following OVX overlaid from control (black, 14 SEs from 4 animals) and PNA (red, 10 SEs from 4 animals). (<bold>G</bold>) FWHM length of OVX control and PNA animals (n=4). Mann-Whitney U test. (<bold>H</bold>) Durations of upswing and downswing for control and PNA animals (n=4), respectively. <italic>P</italic> &gt; 0.05, Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Data show mean ± SEM. Each circle is an individual animal.</p></caption>
<graphic xlink:href="597387v1_fig8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>It is important to establish animal models that faithfully recapitulate the symptoms and features of women with PCOS to be able to make progress in treating the disorder (<xref ref-type="bibr" rid="c61">Stener-Victorin, Padmanabhan et al. 2020</xref>). Increased LH pulse frequency is observed in ∼75% of women with PCOS and is considered to be a significant contributor to their sub-fertility (<xref ref-type="bibr" rid="c64">Taylor, McCourt et al. 1997</xref>). We provide here a detailed assessment of the GnRH pulse generator in two commonly used mouse models of PCOS. The obese PPA mouse model was found to have a pulse generator that actually operates at a slower frequency than normal. In contrast, the PNA mouse model has a pulse generator that is operating faster than normal but, remarkably, maintains cyclical-like patterns of activity despite being in reproductively acyclic mice.</p>
<sec id="s3a">
<title>Pulse generator activity in PPA mice</title>
<p>The chronic administration of DHT to female mice from postnatal day 21 generates an androgen receptor-dependent mouse model of PCOS with infertility and metabolic disturbances (<xref ref-type="bibr" rid="c7">Caldwell, Middleton et al. 2014</xref>, <xref ref-type="bibr" rid="c8">Caldwell, Edwards et al. 2017</xref>, <xref ref-type="bibr" rid="c61">Stener-Victorin, Padmanabhan et al. 2020</xref>, <xref ref-type="bibr" rid="c29">Kerbus, Decourt et al. 2024</xref>). In agreement with those prior studies, we found that PPA mice start to exhibit increased body weight around four weeks after DHT exposure and are acyclic. Fiber photometry revealed that the frequency of ARN<sup>KISS</sup> neuron SEs was reduced by ∼50% in PPA mice compared to controls. This clearly indicates that the PPA mouse does not provide an appropriate PCOS model of elevated pulse generator activity. Given this, we did not proceed to examine pulsatile LH secretion in PPA mice but note that a recent study has reported pulsatile LH secretion to be unchanged in this animal model (<xref ref-type="bibr" rid="c12">Coyle, Prescott et al. 2022</xref>). It is very likely that chronic excess androgen activation in this model provides additional negative feedback suppression of ARN<sup>KISS</sup> neurons. The treatment of adult OVX female mice with the same DHT regimen is reported to decrease LH pulse frequency and amplitude (<xref ref-type="bibr" rid="c16">Esparza, Terasaka et al. 2020</xref>).</p>
</sec>
<sec id="s3b">
<title>Variable reproductive parameters of the PNA mouse model</title>
<p>The PNA mouse model has been studied by many different research groups with some features being identified in a highly consistent manner while others are not (<xref ref-type="bibr" rid="c61">Stener-Victorin, Padmanabhan et al. 2020</xref>). Common characteristics, also present in the current study, are those of increased anogenital distance, normal body weight, and highly disrupted estrous cycles (<xref ref-type="bibr" rid="c63">Sullivan and Moenter 2004</xref>, <xref ref-type="bibr" rid="c58">Silva, Prescott et al. 2018</xref>, <xref ref-type="bibr" rid="c61">Stener-Victorin, Padmanabhan et al. 2020</xref>, <xref ref-type="bibr" rid="c17">Gibson, Jaime et al. 2021</xref>, <xref ref-type="bibr" rid="c36">McCarthy, Dischino et al. 2021</xref>). In contrast, reported differences in circulating gonadal steroid concentrations in PNA mice have been inconsistent among studies. Using ELISAs, some studies have demonstrated PNA mice to have elevated testosterone levels (<xref ref-type="bibr" rid="c63">Sullivan and Moenter 2004</xref>, <xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>, <xref ref-type="bibr" rid="c58">Silva, Prescott et al. 2018</xref>) while others (<xref ref-type="bibr" rid="c56">Roland and Moenter 2011</xref>), including ourselves now, find no differences. Concerns over the specificity and selectivity of ELISAs for measuring gonadal steroids in mice (<xref ref-type="bibr" rid="c25">Handelsman and Wartofsky 2013</xref>, <xref ref-type="bibr" rid="c2">Auchus 2014</xref>, <xref ref-type="bibr" rid="c74">Wierman, Auchus et al. 2014</xref>, <xref ref-type="bibr" rid="c24">Handelsman, Jimenez et al. 2015</xref>) led us to re-assess gonadal steroid hormone levels using gold-standard ultrasensitive LC-MS (<xref ref-type="bibr" rid="c23">Handelsman, Gibson et al. 2020</xref>). We previously observed that testosterone levels were usually below the limit of detection in C57/BL6 female mice (<xref ref-type="bibr" rid="c70">Wall, Desai et al. 2023</xref>) but considered that any elevated concentrations in PNA mice might become detectable. Unfortunately, this was not the case, and it remains unclear if testosterone levels are elevated in PNA mice. We were, however, able to detect estradiol and progesterone concentrations and find that neither is different between control and PNA mice. A prior ELISA assessment also reported that estradiol and progesterone levels were unchanged in PNA animals (<xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>).</p>
<p>Another area of considerable inconsistency among studies involves the effects of PNA treatment on both mRNA and protein expression of kisspeptin, neurokinin B, and dynorphin in the ARN (<xref ref-type="bibr" rid="c77">Yan, Yuan et al. 2014</xref>, <xref ref-type="bibr" rid="c48">Osuka, Iwase et al. 2016</xref>, <xref ref-type="bibr" rid="c17">Gibson, Jaime et al. 2021</xref>, <xref ref-type="bibr" rid="c36">McCarthy, Dischino et al. 2021</xref>, <xref ref-type="bibr" rid="c40">Moore, Lohr et al. 2021</xref>). We re-investigated this question by quantifying the immunoreactive levels of these three proteins and observed an increase in only kisspeptin expression and only in rostral ARN of PNA animals. While there are important roles for these neuropeptides in modulating ARN<sup>KISS</sup> neuron synchronizations (<xref ref-type="bibr" rid="c22">Han, Morris et al. 2023</xref>, <xref ref-type="bibr" rid="c45">Morris and Herbison 2023</xref>) and their subsequent activation of GnRH secretion (<xref ref-type="bibr" rid="c34">Liu, Yeo et al. 2021</xref>), these generally inconsistent findings indicate that any PNA-induced changes in the expression of the neuropeptides are subtle. Indeed, the principal determinant of kisspeptin, neurokinin B, and dynorphin expression in ARN<sup>KISS</sup> neurons is estradiol (<xref ref-type="bibr" rid="c46">Navarro, Gottsch et al. 2009</xref>) and we demonstrate here that circulating estradiol levels are not altered in PNA mice.</p>
</sec>
<sec id="s3c">
<title>Pulse generator activity and pulsatile LH in the PNA mouse model</title>
<p>One of the key features of the PNA mouse model is thought to be that of increased pulsatile LH secretion (<xref ref-type="bibr" rid="c61">Stener-Victorin, Padmanabhan et al. 2020</xref>). However, this has only been reported in a single study with PNA mice exhibiting an approximately 40% increase in LH pulse frequency (<xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>). A recent paper undertaking the same tail-tip pulse bleeding approach found that LH pulse frequency was not significantly altered in PNA mice (<xref ref-type="bibr" rid="c36">McCarthy, Dischino et al. 2021</xref>). Our present observations may explain these discrepancies. As the pulse generator continues to cycle in the acyclic PNA mouse, it is essentially impossible to define the “pulse generator stage” of a PNA mouse at the time of bleeding and consequently wide variations in LH pulse frequency would be expected. We find here that LH pulse frequency recorded from such random “pulse generator” cycling wild-type PNA mice is not significantly different to that of controls. Nevertheless, with the benefit of being able to measure ARN<sup>KISS</sup> neuron activity directly, it has been possible to show that “diestrous-stage” PNA mice do have an increased rate of pulse generator frequency compared with controls. As such, the PNA mouse model does to some degree replicate the increased pulse frequency seen in many women with PCOS.</p>
<p>The most striking feature of pulse generator activity in PNA mice is its ability to retain cyclical patterns of activity within a reproductively acyclic mouse. The pulse generator of PNA mice exhibits clear transitions from periods of “estrous-like” Cluster_0 activity through to mpSE-dominated Cluster_3/4 phase and onto regular “diestrous-like” Cluster_1&amp;_2 patterns. The percentage of time PNA mice spend in each pattern of activity was not found to be significantly different to controls. We also note that the dynamics of individual ARN<sup>KISS</sup> neuron SEs remain unchanged under all conditions in PNA mice, suggesting that the fundamental synchronization mechanism and numbers of contributing neurons is not altered (<xref ref-type="bibr" rid="c22">Han, Morris et al. 2023</xref>). This is consistent with the observation that PNA treatment does not alter ARN<sup>KISS</sup> neuron firing activity in adult acute brain slices (<xref ref-type="bibr" rid="c17">Gibson, Jaime et al. 2021</xref>). Together, these observations indicate that the acyclic reproductive phenotype of PNA mice does not result from an absence of cyclical activity in the pulse generator. Equally, a significant impact of PNA treatment on the activity of the GnRH neuron can be excluded (<xref ref-type="bibr" rid="c28">Jaime and Moenter 2022</xref>) and, at least in mice, pulse generation occurs autonomously at the GnRH neuron distal dendron with no role for GnRH neuron cell bodies (<xref ref-type="bibr" rid="c72">Wang, Guo et al. 2020</xref>, <xref ref-type="bibr" rid="c27">Herbison 2021</xref>). The degree to which cyclical GnRH pulse generator activity in PNA mice reflects women with PCOS is unknown. However, a very wide range of LH pulse frequency is found in anovulatory women with PCOS (<xref ref-type="bibr" rid="c64">Taylor, McCourt et al. 1997</xref>), suggesting the intriguing possibility that the GnRH pulse generator activity may also continue to cycle in women with PCOS.</p>
</sec>
<sec id="s3d">
<title>Gonadal steroid feedback in PNA mice</title>
<p>Pulse generator activity was found to be identical in ovariectomized PNA and control mice. This indicates that, despite androgen receptors being expressed by ARN<sup>KISS</sup> neurons in the perinatal period (<xref ref-type="bibr" rid="c73">Watanabe, Fisher et al. 2023</xref>), excess DHT exposure at this time does not engender any fundamental differences in their synchronization behavior in the absence of gonads as adults. This suggests that the subtle increase in pulse generator frequency detected here in “diestrous-like” PNA mice arises from the effects of circulating gonadal steroids. As gonadal steroid levels are normal in PNA mice, it is likely that perinatal DHT exposure programs long-term changes in gonadal steroid receptor function in adult PNA mice. While direct estrogen feedback is critical in maintaining the suppressed activity of the pulse generator throughout the estrous cycle (<xref ref-type="bibr" rid="c37">McQuillan, Clarkson et al. 2022</xref>), ARN<sup>KISS</sup> neuron ESR1 expression was not found to be altered in PNA mice (<xref ref-type="bibr" rid="c40">Moore, Lohr et al. 2021</xref>).</p>
<p>Reduced progesterone negative feedback is widely considered to be a major factor underlying enhanced LH pulsatility in women with PCOS (<xref ref-type="bibr" rid="c49">Pastor, Griffin-Korf et al. 1998</xref>, <xref ref-type="bibr" rid="c9">Chhabra, McCartney et al. 2005</xref>) and the ability of progesterone to suppress LH secretion is reduced in OVX PNA mice (<xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>). Whereas progesterone exerts a robust and prolonged suppression of ARN<sup>KISS</sup> neuron SEs in normal (<xref ref-type="bibr" rid="c39">McQuillan, Han et al. 2019</xref>) and control mice, we find this to be much less effective in PNA females. Precisely how perinatal DHT treatment desensitizes ARN<sup>KISS</sup> neurons to progesterone is unknown and could occur directly or indirectly (<xref ref-type="bibr" rid="c40">Moore, Lohr et al. 2021</xref>). Reported effects of PNA on progesterone receptors in the ARN are inconsistent with studies reporting either reduced or unchanged expression (<xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>, <xref ref-type="bibr" rid="c17">Gibson, Jaime et al. 2021</xref>, <xref ref-type="bibr" rid="c40">Moore, Lohr et al. 2021</xref>), although one recent study found a 30% reduction in progesterone receptor mRNA expression by ARN<sup>KISS</sup> neuron in PNA mice (<xref ref-type="bibr" rid="c40">Moore, Lohr et al. 2021</xref>).</p>
<p>Although we find that the PNA mouse has reduced progesterone feedback at the level of the pulse generator, as is suspected for women with PCOS, it is unclear how this might pattern ARN<sup>KISS</sup> neuron activity. Control and PNA mice exhibit similar proportions of time with halted or slow pulse generator activity (Cluster_0). This pattern of activity is thought to occur in response to increased progesterone level following the LH surge (<xref ref-type="bibr" rid="c39">McQuillan, Han et al. 2019</xref>, <xref ref-type="bibr" rid="c68">Vas, Wall et al. 2024</xref>). Thus, it is somewhat perplexing to find clear Cluster_0 activity in PNA mice that have reduced sensitivity to progesterone negative feedback. This might suggest that in other mechanisms can become responsible for luteal phase slowing of pulse generator activity in PNA mice. Equally, is unclear how reduced progesterone feedback could elevate the “diestrous-like” pattern of ARN<sup>KISS</sup> neuron activity, although roles for progesterone outside the luteal phase have been suggested (<xref ref-type="bibr" rid="c32">Leipheimer, Bona-Gallo et al. 1984</xref>).</p>
<p>Previous studies have demonstrated that the estrogen-activated LH surge mechanism is normal in PNA mice (<xref ref-type="bibr" rid="c41">Moore, Prescott et al. 2013</xref>) and, despite proestrous smears never being observed in PNA mice, copra lutea can be found suggesting that LH surges and ovulation can occur (<xref ref-type="bibr" rid="c41">Moore, Prescott et al. 2013</xref>, <xref ref-type="bibr" rid="c31">Lei, Ding et al. 2017</xref>, <xref ref-type="bibr" rid="c36">McCarthy, Dischino et al. 2021</xref>). This raises the intriguing possibility that the GnRH surge generator may also be operational in PNA mice but masked by abnormal downstream signalling. In that regard, we note that pituitary gonadotroph sensitivity to GnRH is blunted in PNA mice as previously reported (<xref ref-type="bibr" rid="c59">Silva, Desroziers et al. 2019</xref>). Given that pulse generator activity is the same in ovariectomized PNA and control mice, reduced gonadotroph sensitivity would explain the reduced rise in LH following ovariectomy in PNA mice observed in other studies (<xref ref-type="bibr" rid="c41">Moore, Prescott et al. 2013</xref>, <xref ref-type="bibr" rid="c42">Moore, Prescott et al. 2015</xref>). Nevertheless, we note that the PNA mouse clearly does not model women with PCOS that show a much-elevated LH response to GnRH (<xref ref-type="bibr" rid="c3">Barnes, Rosenfield et al. 1989</xref>, <xref ref-type="bibr" rid="c5">Batrinos 1993</xref>, <xref ref-type="bibr" rid="c44">Morales, Laughlin et al. 1996</xref>, <xref ref-type="bibr" rid="c50">Patel, Coffler et al. 2003</xref>)</p>
<p>In summary, we report here that the GnRH pulse generator operates at a lower frequency in PPA mice, but at a higher frequency when “diestrous-like” pulse generator activity was analyzed in PNA mice. From the perspective of understanding enhanced pulsatile LH secretion in women with PCOS, the PNA model is clearly the most appropriate model. However, we note that many features of PNA mice such as their pulse generator free-running behavior in the ovariectomized state and gonadal steroid hormone concentrations are normal. Remarkably, we find evidence that the pulse generator continues to exhibit estrous cycle-like patterns of activity within an acyclic PNA mouse model. Thus, the anovulatory phenotype of PNA mice arises in a complex manner from deficits likely at many levels of the hypothalamo-pituitary-ovarian axis. The degree to which the PNA mouse model reflects women with PCOS remains an important, albeit very difficult, question to address.</p>
</sec>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Mice</title>
<p>Female 129S6Sv/Ev C57BL/6 <italic>Kiss1<sup>Cre/+</sup></italic>mice (<xref ref-type="bibr" rid="c78">Yeo, Kyle et al. 2016</xref>) were crossed with the Ai162 (TIT2L-GC6s-ICL-tTA2)-D Cre-dependent GCaMP6s males (JAX stock #031562) (<xref ref-type="bibr" rid="c13">Daigle, Madisen et al. 2018</xref>) to generate <italic>Kiss1</italic>-Cre/+,<italic>Ai126D</italic> mice as previously characterized (<xref ref-type="bibr" rid="c22">Han, Morris et al. 2023</xref>). Mice were group-housed in conventional cages with environmental enrichment under conditions of controlled temperature (22 ± 2 <sup>0</sup>C) and lighting (12-hour light/12-hour dark cycle; lights on at 05:30 or 07:00) with <italic>ad libitum</italic> access to food (RM3 (E), Special Diets Services, UK) and water. All animal experimental protocols were approved by the University of Cambridge, UK (P174441DE). Where required, mice were bilaterally ovariectomized (OVX) under isoflurane anesthesia at least 3 weeks prior to experimentation.</p>
</sec>
<sec id="s4b">
<title>Peripubertal androgen (PPA) model</title>
<p>Peripubertal female mice were exposed to DHT as previously described (<xref ref-type="bibr" rid="c67">van Houten, Kramer et al. 2012</xref>, <xref ref-type="bibr" rid="c8">Caldwell, Edwards et al. 2017</xref>). Briefly, peripubertal female mice (21-23 days old) were implanted subcutaneously (s.c.) with either an empty (control) or dihydrotestosterone (DHT)-filled (PPA) 1-cm silastic implants (id, 1.47 mm; od, 1.95 mm, Dow Corning Corp, catalog no. 508–006). These silastic implants containing ∼10 mg DHT provide steady-state DHT release for at least 6 months (<xref ref-type="bibr" rid="c60">Singh, O’Neill et al. 1995</xref>). The body weight of these animals was monitored weekly until optic fiber implantation at the 10 weeks of age.</p>
</sec>
<sec id="s4c">
<title>Prenatal androgen (PNA) model</title>
<p>Adult females were paired with males and checked for copulatory plugs, indicating day 1 of gestation. Pregnant dams were given s.c. injections of sesame oil vehicle (100 μL) alone or containing 250 μg of DHT on gestational days 16, 17, and 18 (<xref ref-type="bibr" rid="c63">Sullivan and Moenter 2004</xref>). Female offspring from androgen-treated (PNA) and vehicle-treated (control) dams were used for experiments.</p>
</sec>
<sec id="s4d">
<title>Estrous cycle determination</title>
<p>The estrous cycle stage was determined by the relative ratio of leukocytes, cornified, and nucleated cells observed in the vaginal epithelial cell smear samples on the morning of collection (<xref ref-type="bibr" rid="c1">Ajayi and Akhigbe 2020</xref>). The smears were collected using 5 μL of sterile phosphate-buffered saline (PBS) which was transferred to a glass slide to air dry before staining with filtered Giemsa (1:1 in MilliQ water) and examined under a light microscope.</p>
</sec>
<sec id="s4e">
<title>Testosterone ELISA measurements and analysis</title>
<p>Blood samples for testosterone measurement were collected in the afternoon of diestrus through a tail-tip blood sample prior to ovariectomy or from the inferior vena cava before perfusion. The samples were then spun at room temperature at 3,000 rpm for 10 minutes. Serum was collected and kept at –20°C until the day of hormone measurement. Serum testosterone levels were measured using the testosterone rat/mouse ELISA kit according to the manufacturer’s instructions (Demeditec Diagnostics, GmbH, DEV9911, Kiel, Bermany). The assay sensitivity for mouse testosterone ELISA was 0.066 ng/mL, and intra-assay coefficient of variation was 6.5%.</p>
</sec>
<sec id="s4f">
<title>Liquid Chromatography–Mass Spectrometry (LC-MS)</title>
<p>Terminal blood samples were collected from the inferior vena cava of anaesthetized control and PNA animals at 10:00 on diestrus exactly as described previously (<xref ref-type="bibr" rid="c70">Wall, Desai et al. 2023</xref>). Plasma levels of estradiol, progesterone, testosterone, and androstenedione were measured using liquid chromatography-mass spectrometry (LC-MS) (<xref ref-type="bibr" rid="c23">Handelsman, Gibson et al. 2020</xref>).</p>
</sec>
<sec id="s4g">
<title>Quantification of kisspeptin/neurokinin B/dynorphin expression in ARN</title>
<p>Adult diestrous PNA and control female mice were given a lethal dose of pentobarbital (3 mg/100µL, intraperitoneal, i.p.) and perfused transcardially with 4% paraformaldehyde (PFA). Brains were post-fixed in 4% PFA for 1 hour at 4°C and transferred to 30% sucrose at 4°C until sunk. Forty-µm-thick sections were collected with microtomes and processed for kisspeptin and neurokinin B (NKB) immunofluorescence and dynorphin (DYN) Nickel-3,3′-Diaminobenzidine (DAB) staining. For kisspeptin staining, brain sections were incubated with rabbit anti-kisspeptin (1:5,000, AC566; a gift from Dr. Alain Caraty) followed by goat anti-rabbit Alexa Fluor 568 (1:500, Molecular Probes). For NKB staining, brain sections were incubated with guinea pig anti-NKB (1:5,000, IS-3/61, a gift from Dr. Philippe Ciofi) followed by biotinylated goat anti-guinea pig IgG (1:1,000, Vector Laboratories) and DyLight Streptavidin 488 (1:500, BioLegend). Images were taken using a Leica SP8 Laser Scanning Confocal Microscope (Leica Microsystems) at the Cambridge Advanced Imaging Center and analyzed using ImageJ. Brain sections for DYN Nickel DAB labeling were incubated with rabbit anti-DYN B (1:12,000, a gift from Dr. Philippe Ciofi) (<xref ref-type="bibr" rid="c20">Griffond, Deray et al. 1993</xref>) followed by biotinylated goat anti-rabbit IgG (1:200, Vector Laboratories). Brain sections were further incubated in avidin-biotin peroxidase solution before reacting with Nickel DAB developing solution. Images were taken using an Olympus BX43 upright microscope with DP74 digital camera (Olympus Life Science) and analyzed using Image J.</p>
</sec>
<sec id="s4h">
<title>Stereotaxic surgery and GCaMP fiber photometry</title>
<p>Adult female PNA, PPA, and their respective control <italic>Kiss1</italic>-Cre/+,<italic>Ai126D</italic> mice (10-14 weeks old) were anesthetized with 2% isoflurane, given meloxicam (5 mg/kg, s.c.), buprenorphine (0.05 mg/kg, s.c.), and dexamethasone (10 mg/kg, s.c.) and placed in a stereotaxic apparatus. A small hole was drilled in the skull and a unilateral indwelling optical fiber (400 µm diameter; 0.48 NA, Doric LenSEs, Quebec, Canada) was implanted directly above the mid-caudal ARN (2.0 mm posterior to bregma, 3.0 mm lateral to the superior sagittal sinus, 5.93 mm deep). Following optic fiber implantation, mice were monitored through recovery for 5 days and received post-operative analgesics (meloxicam, 5 mg/kg; orally) for up to two days. Then mice were handled daily for at least 3 weeks and habituated to the fiber photometry recording setup before fluorescence signals were recorded from freely behaving mice in their home cages.</p>
<p>Fiber photometry was undertaken as detailed previously (<xref ref-type="bibr" rid="c10">Clarkson, Han et al. 2017</xref>). Photometry systems were built using Doric components (Doric Lenses, QC, Canada) and National Instrument data acquisition board (TX, USA) based on a previous design (<xref ref-type="bibr" rid="c33">Lerner, Shilyansky et al. 2015</xref>). Blue (465-490 nm) and violet (405 nm) LED lights were sinusoidally modulated at frequencies of 531 and 211 Hz respectively. Both lights were focused onto a single fiber optic connected to the mouse. The light intensity at the tip of the fiber was 30-80 micro watts. Emitted fluorescence signal from the brain was collected via the same fiber, passed through a 500-550 nm emission filter, before focused onto a fluorescence detector (Doric, QC, Canada). The emissions were collected at 10 Hz and the two GCaMP6 emissions were recovered by demodulating the 465-490 nm signals (calcium-dependent) and 405 nm (calcium independent) signals.</p>
<p>Fluorescence signals were sampled using either a scheduled mode (5/15 seconds on/off) or a continuous mode of light emission with custom software (Tussock Innovation). Twenty-four-hour recordings were made from PNA, PPA, and their respective control female mice in the diestrous stage starting 4 hours after lights-on. Four-day recordings were started on proestrus for control mice and on any diestrous or metestrous stage for PNA mice. Continuous data acquisition mode was used to provide high temporal resolution comparisons of SEs. Signals from each SE were normalized to its peak (intact: -120 to +120 seconds; OVX: -120 to +200 seconds from the peak time). The full widths at half maximum (FHWM) of SE were determined at half-maximal amplitude of the normalized SEs. Averaged SE parameters for each animal were calculated before computing the means for each treatment group.</p>
<p>Analysis was performed in MATLAB with the subtraction of 405 signal from 465-490 signal to extract the calcium-dependent fluorescence signal. An exponential fit algorithm was used to correct for baseline shift. The signal was calculated in dF/F (%) with the equation dF/F = (F<sub>fluorescence</sub>-F<sub>baseline</sub>)/F<sub>baseline</sub>) x 100. The Findpeaks algorithm was used to detect SEs with peaks in dF/F greater than 50% of the maximum signal in each recording. Inter-SE intervals represent the time between peak values of each SEs. Multi-peak SE in PNA animals and cluster SE in OVX were analyzed as one SE and SE intervals were calculated from the first peak.</p>
</sec>
<sec id="s4i">
<title>Serial blood sampling, GnRH injection, and LH measurement</title>
<p>Mice were handled daily for at least 3 weeks to habituate for tail-tip bleeding. To examine the relationship between ARN<sup>KISS</sup> neuron SEs and pulsatile LH secretion, freely behaving mice were attached to the fiber photometry system, and 4 µL blood samples were taken every 6 or 12 min from the tail-tip over a period of 2 to 4 hours during recording. For standard serial blood sampling experiments, LH secretion was measured by obtaining 4 µL blood samples every 10 minutes for 4 hours (between 12:00 and 17:00). At the end of the bleeding period, 200 ng/kg body weight of GnRH (Bachem, catalog No. 4033013, Switzerland) was injected i.p., and two more blood samples were collected at 10-minute intervals. Whole blood samples were diluted 1:15 in 1x PBS with 0.05% Tween 20 (PBS-T) for LH ELISA (<xref ref-type="bibr" rid="c62">Steyn, Wan et al. 2013</xref>), an assay sensitivity of 0.04 ng/mL, as well as intra-assay and interassay coefficients of variation of 9.3% and 10.5%, respectively. Pulses were defined and analyzed by PULSAR with the settings optimized for intact female mice: G1 = 3.5, G2 = 2.6, G3 = 1.9, G4 = 1.5, and G5 = 1.2 (<xref ref-type="bibr" rid="c52">Porteous, Haden et al. 2021</xref>).</p>
</sec>
<sec id="s4j">
<title>K-means clustering</title>
<p>Data analysis and unsupervised k-means clustering analysis were performed without vaginal cytology information as previously described (<xref ref-type="bibr" rid="c68">Vas, Wall et al. 2024</xref>). Synchronization events with multiple peaks occurring within 160s were defined as mpSEs. In brief, 4-day recordings were segmented into 24-hour periods before applying a customized MATLAB code to extract features of the population activity of the ARN<sup>KISS</sup> neurons including the (i) number of SEs within a given time period; (ii) prevalence of different type of SEs (single- and mpSEs); (iii) inter-SE intervals, variation in the inter-SE intervals (reflecting regularity of activity patterns); and (iv) shape of the SEs (height, variation in height, half-duration). These 24-hour periods were further fragmented using a 7-hour window size with 1-hour sliding steps. The first and the last 3 hours of each 24-hour recording were extrapolated from the assignment of the 4<sup>th</sup> and 21<sup>st</sup> hours, respectively. The following parameters were used to describe the activity pattern of ARN<sup>KISS</sup> neurons: (i) number of SEs, where mpSEs were counted as a single SE; (ii) standard deviation (SD) of inter-SE intervals; (iii) number of mpSEs; (iv) average number of peaks within an mpSEs; and (v) average duration of mpSEs. All these parameter values were then linearly rescaled to values between 0 and 1. To perform k-means clustering on the data set, we used RapidMiner Studio’s (<ext-link ext-link-type="uri" xlink:href="https://rapidminer.com">https://rapidminer.com</ext-link>, educational license) built-in module (k = 5, number of runs with random initiations = 100, measure types = “NumericalMeasures”, numerical measure = “EuclideanDistance”, max optimization steps = 100). Cluster centroid data and cluster labels (to each 7-hour time window) were exported from RapidMiner Studio and were visualized in R (using “ggplot2”, “readr” and “fmsb” libraries).</p>
</sec>
<sec id="s4k">
<title>Progesterone injection</title>
<p>Progesterone stock solution (800 µg/mL) was prepared by dissolving 8 mg of progesterone (Sigma, Catalog No. P0130) in 1 mL ethanol followed by 1:10 dilution in sesame oil. Diestrous female mice were recorded for 3 hours before an i.p. injection of progesterone (4 mg/kg body weight) or vehicle (100 μL, sesame oil). A previous study has shown that i.p. injection of progesterone at 8 mg/kg body weight to C57BL/6 mice results in peak circulating progesterone concentrations of 110 ng/mL before dropping to 34 ng/mL 1 hour later (<xref ref-type="bibr" rid="c76">Wong, Ray et al. 2012</xref>). Circulating progesterone levels at proestrus in C57BL/6 mice are 22 ± 4 ng/mL (<xref ref-type="bibr" rid="c70">Wall, Desai et al. 2023</xref>), so we employed half of this dose to test the sensitivity of progesterone negative feedback to ARN<sup>KISS</sup> neurons.</p>
</sec>
<sec id="s4l">
<title>Statistical analysis</title>
<p>All statistical analyses were performed using GraphPad Prism 10 software. Depending on different experimental designs, and the nature of data distribution, data were analyzed by Mann-Whitney U tests, Kruskal-Wallis test followed by Dunn’s multiple comparison tests, two-way ANOVA followed by Sidak’s multiple comparisons test, or two-way repeated-measures ANOVA followed by Sidak’s multiple comparisons test. The threshold level for statistical significance was set at <italic>P</italic> &lt; 0.05 with data presented as mean ± SEM with each dot representing one animal.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgement</title>
<p>This research was supported by the Wellcome Trust (212242/Z/18/Z) to AEH and Medical Research Council (MR N013433-1) and Harding Distinguished Postgraduate Scholars Programme Leverage Scheme to ZZ.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Ajayi</surname>, <given-names>A. F.</given-names></string-name> and <string-name><given-names>R. E.</given-names> <surname>Akhigbe</surname></string-name> (<year>2020</year>). “<article-title>Staging of the estrous cycle and induction of estrus in experimental rodents: an update</article-title>.” <source>Fertil Res Pract</source> <volume>6</volume>: <fpage>5</fpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Auchus</surname>, <given-names>R. J</given-names></string-name>. (<year>2014</year>). “<article-title>Steroid assays and endocrinology: best practices for basic scientists</article-title>.” <source>Endocrinology</source> <volume>155</volume>(<issue>6</issue>): <fpage>2049</fpage>–<lpage>2051</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Barnes</surname>, <given-names>R. B.</given-names></string-name>, <string-name><given-names>R. L.</given-names> <surname>Rosenfield</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Burstein</surname></string-name> and <string-name><given-names>D. A.</given-names> <surname>Ehrmann</surname></string-name> (<year>1989</year>). “<article-title>Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome</article-title>.” <source>N Engl J Med</source> <volume>320</volume>(<issue>9</issue>): <fpage>559</fpage>–<lpage>565</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Barnes</surname>, <given-names>R. B.</given-names></string-name>, <string-name><given-names>R. L.</given-names> <surname>Rosenfield</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Burstein</surname></string-name> and <string-name><given-names>D. A.</given-names> <surname>Ehrmann</surname></string-name> (<year>1989</year>). “<article-title>Pituitary-Ovarian Responses to Nafarelin Testing in the Polycystic Ovary Syndrome</article-title>.” <source>New England Journal of Medicine</source> <volume>320</volume>(<issue>9</issue>): <fpage>559</fpage>–<lpage>565</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Batrinos</surname>, <given-names>M. L</given-names></string-name>. (<year>1993</year>). “<article-title>Diagnostic Dilemmas in Polycystic Ovarian Syndrome</article-title>.” <source>Annals of the New York Academy of Sciences</source> <volume>687</volume>(<issue>1</issue>): <fpage>230</fpage>–<lpage>234</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Bozdag</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Mumusoglu</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Zengin</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Karabulut</surname></string-name> and <string-name><given-names>B. O.</given-names> <surname>Yildiz</surname></string-name> (<year>2016</year>). “<article-title>The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis</article-title>.” <source>Human Reproduction</source> <volume>31</volume>(<issue>12</issue>): <fpage>2841</fpage>–<lpage>2855</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Caldwell</surname>, <given-names>A. S.</given-names></string-name>, <string-name><given-names>L. J.</given-names> <surname>Middleton</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Jimenez</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Desai</surname></string-name>, <string-name><given-names>A. C.</given-names> <surname>McMahon</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Allan</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name> and <string-name><given-names>K. A.</given-names> <surname>Walters</surname></string-name> (<year>2014</year>). “<article-title>Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models</article-title>.” <source>Endocrinology</source> <volume>155</volume>(<issue>8</issue>): <fpage>3146</fpage>–<lpage>3159</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Caldwell</surname>, <given-names>A. S. L.</given-names></string-name>, <string-name><given-names>M. C.</given-names> <surname>Edwards</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Desai</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Jimenez</surname></string-name>, <string-name><given-names>R. B.</given-names> <surname>Gilchrist</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name> and <string-name><given-names>K. A.</given-names> <surname>Walters</surname></string-name> (<year>2017</year>). “<article-title>Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome</article-title>.” <source>Proc Natl Acad Sci U S A</source> <volume>114</volume>(<issue>16</issue>): <fpage>E3334</fpage>–<lpage>e3343</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Chhabra</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>C. R.</given-names> <surname>McCartney</surname></string-name>, <string-name><given-names>R. Y.</given-names> <surname>Yoo</surname></string-name>, <string-name><given-names>C. A.</given-names> <surname>Eagleson</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Chang</surname></string-name> and <string-name><given-names>J. C.</given-names> <surname>Marshall</surname></string-name> (<year>2005</year>). “<article-title>Progesterone Inhibition of the Hypothalamic Gonadotropin-Releasing Hormone Pulse Generator: Evidence for Varied Effects in Hyperandrogenemic Adolescent Girls</article-title>.” <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>90</volume>(<issue>5</issue>): <fpage>2810</fpage>–<lpage>2815</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Clarkson</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>S. Y.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Piet</surname></string-name>, <string-name><given-names>T.</given-names> <surname>McLennan</surname></string-name>, <string-name><given-names>G. M.</given-names> <surname>Kane</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ng</surname></string-name>, <string-name><given-names>R. W.</given-names> <surname>Porteous</surname></string-name>, <string-name><given-names>J. S.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>W. H.</given-names> <surname>Colledge</surname></string-name>, <string-name><given-names>K. J.</given-names> <surname>Iremonger</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2017</year>). “<article-title>Definition of the hypothalamic GnRH pulse generator in mice</article-title>.” <source>Proc Natl Acad Sci U S A</source> <volume>114</volume>(<issue>47</issue>): <fpage>E10216</fpage>–<lpage>e10223</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Coutinho</surname>, <given-names>E. A.</given-names></string-name> and <string-name><given-names>A. S.</given-names> <surname>Kauffman</surname></string-name> (<year>2019</year>). “<article-title>The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS)</article-title>.” <source>Med Sci (Basel)</source> <volume>7</volume>(<issue>8</issue>).</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Coyle</surname>, <given-names>C. S.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Prescott</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Walters</surname></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2022</year>). “<article-title>Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons</article-title>.” <source>Journal of Neuroendocrinology</source> <volume>34</volume>(<issue>4</issue>): <fpage>e13110</fpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Daigle</surname>, <given-names>T. L.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Madisen</surname></string-name>, <string-name><given-names>T. A.</given-names> <surname>Hage</surname></string-name>, <string-name><given-names>M. T.</given-names> <surname>Valley</surname></string-name>, <string-name><given-names>U.</given-names> <surname>Knoblich</surname></string-name>, <string-name><given-names>R. S.</given-names> <surname>Larsen</surname></string-name>, <string-name><given-names>M. M.</given-names> <surname>Takeno</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Gu</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Larsen</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mills</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bosma-Moody</surname></string-name>, <string-name><given-names>L. A.</given-names> <surname>Siverts</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Walker</surname></string-name>, <string-name><given-names>L. T.</given-names> <surname>Graybuck</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Yao</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Fong</surname></string-name>, <string-name><given-names>T. N.</given-names> <surname>Nguyen</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Garren</surname></string-name>, <string-name><given-names>G. H.</given-names> <surname>Lenz</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Chavarha</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Pendergraft</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Harrington</surname></string-name>, <string-name><given-names>K. E.</given-names> <surname>Hirokawa</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Harris</surname></string-name>, <string-name><given-names>P. R.</given-names> <surname>Nicovich</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>McGraw</surname></string-name>, <string-name><given-names>D. R.</given-names> <surname>Ollerenshaw</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>C. A.</given-names> <surname>Baker</surname></string-name>, <string-name><given-names>J. T.</given-names> <surname>Ting</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>Sunkin</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lecoq</surname></string-name>, <string-name><given-names>M. Z.</given-names> <surname>Lin</surname></string-name>, <string-name><given-names>E. S.</given-names> <surname>Boyden</surname></string-name>, <string-name><given-names>G. J.</given-names> <surname>Murphy</surname></string-name>, <string-name><given-names>N. M.</given-names> <surname>da Costa</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Waters</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Tasic</surname></string-name> and <string-name><given-names>H.</given-names> <surname>Zeng</surname></string-name> (<year>2018</year>). “<article-title>A Suite of Transgenic Driver and Reporter Mouse Lines with Enhanced Brain-Cell-Type Targeting and Functionality</article-title>.” <source>Cell</source> <volume>174</volume>(<issue>2</issue>): <fpage>465</fpage>–<lpage>480.</lpage> </mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Dalkin</surname>, <given-names>A. C.</given-names></string-name>, <string-name><given-names>D. J.</given-names> <surname>Haisenleder</surname></string-name>, <string-name><given-names>G. A.</given-names> <surname>Ortolano</surname></string-name>, <string-name><given-names>T. R.</given-names> <surname>Ellis</surname></string-name> and <string-name><given-names>J. C.</given-names> <surname>Marshall</surname></string-name> (<year>1989</year>). “<article-title>The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression</article-title>.” <source>Endocrinology</source> <volume>125</volume>(<issue>2</issue>): <fpage>917</fpage>–<lpage>924</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Dam</surname>, <given-names>E. W. C. M. V.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Roelfsema</surname></string-name>, <string-name><given-names>J. D.</given-names> <surname>Veldhuis</surname></string-name>, <string-name><given-names>F. M.</given-names> <surname>Helmerhorst</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Frölich</surname></string-name>, <string-name><given-names>A. E.</given-names> <surname>Meinders</surname></string-name>, <string-name><given-names>H. M. J.</given-names> <surname>Krans</surname></string-name> and <string-name><given-names>H.</given-names> <surname>Pijl</surname></string-name> (<year>2002</year>). “<article-title>Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS</article-title>.” <source>American Journal of Physiology-Endocrinology and Metabolism</source> <volume>282</volume>(<issue>4</issue>): <fpage>E865</fpage>–<lpage>E872</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Esparza</surname>, <given-names>L. A.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Terasaka</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Lawson</surname></string-name> and <string-name><given-names>A. S.</given-names> <surname>Kauffman</surname></string-name> (<year>2020</year>). “<article-title>Androgen Suppresses In Vivo and In Vitro LH Pulse Secretion and Neural Kiss1 and Tac2 Gene Expression in Female Mice</article-title>.” <source>Endocrinology</source> <volume>161</volume>(<issue>12</issue>).</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Gibson</surname>, <given-names>A. G.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Jaime</surname></string-name>, <string-name><given-names>L. L.</given-names> <surname>Burger</surname></string-name> and <string-name><given-names>S. M.</given-names> <surname>Moenter</surname></string-name> (<year>2021</year>). “<article-title>Prenatal Androgen Treatment Does Not Alter the Firing Activity of Hypothalamic Arcuate Kisspeptin Neurons in Female Mice</article-title>.” <source>eNeuro</source> <volume>8</volume>(<issue>5</issue>).</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Goodman</surname>, <given-names>R. L.</given-names></string-name>, <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name>, <string-name><given-names>M. N.</given-names> <surname>Lehman</surname></string-name> and <string-name><given-names>V. M.</given-names> <surname>Navarro</surname></string-name> (<year>2022</year>). “<article-title>Neuroendocrine control of gonadotropin-releasing hormone: Pulsatile and surge modes of secretion</article-title>.” <source>Journal of Neuroendocrinology</source> <volume>34</volume>(<issue>5</issue>): <fpage>e13094</fpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Goodman</surname>, <given-names>R. L.</given-names></string-name>, <string-name><given-names>I.</given-names> <surname>Holaskova</surname></string-name>, <string-name><given-names>C. C.</given-names> <surname>Nestor</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Connors</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>Billings</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Valent</surname></string-name>, <string-name><given-names>M. N.</given-names> <surname>Lehman</surname></string-name> and <string-name><given-names>S. M.</given-names> <surname>Hileman</surname></string-name> (<year>2011</year>). “<article-title>Evidence that the Arcuate Nucleus Is an Important Site of Progesterone Negative Feedback in the Ewe</article-title>.” <source>Endocrinology</source> <volume>152</volume>(<issue>9</issue>): <fpage>3451</fpage>–<lpage>3460</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Griffond</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Deray</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Fellmann</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Ciofi</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Croix</surname></string-name> and <string-name><given-names>C.</given-names> <surname>Bugnon</surname></string-name> (<year>1993</year>). “<article-title>Colocalization of prolactin- and dynorphin-like substances in a neuronal population of the rat lateral hypothalamus</article-title>.” <source>Neurosci Lett</source> <volume>156</volume>(<issue>1-2</issue>): <fpage>91</fpage>–<lpage>95</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Han</surname>, <given-names>S. Y.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Kane</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Cheong</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2019</year>). “<article-title>Characterization of GnRH Pulse Generator Activity in Male Mice Using GCaMP Fiber Photometry</article-title>.” <source>Endocrinology</source> <volume>160</volume>(<issue>3</issue>): <fpage>557</fpage>–<lpage>567</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Han</surname>, <given-names>S. Y.</given-names></string-name>, <string-name><given-names>P. G.</given-names> <surname>Morris</surname></string-name>, <string-name><given-names>J.-C.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Guru</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pardo-Navarro</surname></string-name>, <string-name><given-names>S.-H.</given-names> <surname>Yeo</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>McQuillan</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2023</year>). “<article-title>Mechanism of kisspeptin neuron synchronization for pulsatile hormone secretion in male mice</article-title>.” <source>Cell Reports</source> <volume>42</volume>(<issue>1</issue>): <fpage>111914</fpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Handelsman</surname>, <given-names>D. J.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Gibson</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Golebiowski</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Walters</surname></string-name> and <string-name><given-names>R.</given-names> <surname>Desai</surname></string-name> (<year>2020</year>). “<article-title>Ultrasensitive Serum Estradiol Measurement by Liquid Chromatography-Mass Spectrometry in Postmenopausal Women and Mice</article-title>.” <source>J Endocr Soc</source> <volume>4</volume>(<issue>9</issue>): <fpage>bvaa086</fpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Handelsman</surname>, <given-names>D. J.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Jimenez</surname></string-name>, <string-name><given-names>G. K. S.</given-names> <surname>Singh</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Spaliviero</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Desai</surname></string-name> and <string-name><given-names>K. A.</given-names> <surname>Walters</surname></string-name> (<year>2015</year>). “<article-title>Measurement of Testosterone by Immunoassays and Mass Spectrometry in Mouse Serum, Testicular, and Ovarian Extracts</article-title>.” <source>Endocrinology</source> <volume>156</volume>(<issue>1</issue>): <fpage>400</fpage>–<lpage>405</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Handelsman</surname>, <given-names>D. J.</given-names></string-name> and <string-name><given-names>L.</given-names> <surname>Wartofsky</surname></string-name> (<year>2013</year>). “<article-title>Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism</article-title>.” <source>J Clin Endocrinol Metab</source> <volume>98</volume>(<issue>10</issue>): <fpage>3971</fpage>–<lpage>3973</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Herbison</surname>, <given-names>A. E</given-names></string-name>. (<year>2018</year>). “<article-title>The Gonadotropin-Releasing Hormone Pulse Generator</article-title>.” <source>Endocrinology</source> <volume>159</volume>(<issue>11</issue>): <fpage>3723</fpage>–<lpage>3736</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Herbison</surname>, <given-names>A. E</given-names></string-name>. (<year>2021</year>). “<article-title>The dendron and episodic neuropeptide release</article-title>.” <source>Journal of Neuroendocrinology</source> <volume>33</volume>(<issue>11</issue>): <fpage>e13024</fpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Jaime</surname>, <given-names>J.</given-names></string-name> and <string-name><given-names>S. M.</given-names> <surname>Moenter</surname></string-name> (<year>2022</year>). “<article-title>GnRH Neuron Excitability and Action Potential Properties Change with Development But Are Not Affected by Prenatal Androgen Exposure</article-title>.” <source>eNeuro</source> <volume>9</volume>(<issue>6</issue>).</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Kerbus</surname>, <given-names>R. I.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Decourt</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Inglis</surname></string-name>, <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> and <string-name><given-names>G. M.</given-names> <surname>Anderson</surname></string-name> (<year>2024</year>). “<article-title>Androgen receptor actions on AgRP neurons are not a major cause of reproductive and metabolic impairments in peripubertally androgenized mice</article-title>.” <source>Journal of Neuroendocrinology</source>: <fpage>e13370</fpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Kumari</surname>, <given-names>A. S.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Haq</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Jayasundaram</surname></string-name>, <string-name><given-names>L. O.</given-names> <surname>Abdel-Wareth</surname></string-name>, <string-name><given-names>S. A.</given-names> <surname>al Haija</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Alvares</surname></string-name> (<year>2005</year>). “<article-title>Metformin monotherapy in lean women with polycystic ovary syndrome</article-title>.” <source>Reproductive BioMedicine Online</source> <volume>10</volume>(<issue>1</issue>): <fpage>100</fpage>–<lpage>104</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Lei</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Ding</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Su</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Sun</surname></string-name> and <string-name><given-names>G.</given-names> <surname>Yan</surname></string-name> (<year>2017</year>). “<article-title>Attenuated expression of MTR in both prenatally androgenized mice and women with the hyperandrogenic phenotype of PCOS</article-title>.” <source>PLoS One</source> <volume>12</volume>(<issue>12</issue>): <fpage>e0187427</fpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Leipheimer</surname>, <given-names>R. E.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Bona-Gallo</surname></string-name> and <string-name><given-names>R. V.</given-names> <surname>Gallo</surname></string-name> (<year>1984</year>). “<article-title>The influence of progesterone and estradiol on the acute changes in pulsatile luteinizing hormone release induced by ovariectomy on diestrus day 1 in the rat</article-title>.” <source>Endocrinology</source> <volume>114</volume>(<issue>5</issue>): <fpage>1605</fpage>–<lpage>1612</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Lerner</surname>, <given-names>T. N.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Shilyansky</surname></string-name>, <string-name><given-names>T. J.</given-names> <surname>Davidson</surname></string-name>, <string-name><given-names>K. E.</given-names> <surname>Evans</surname></string-name>, <string-name><given-names>K. T.</given-names> <surname>Beier</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Zalocusky</surname></string-name>, <string-name><given-names>A. K.</given-names> <surname>Crow</surname></string-name>, <string-name><given-names>R. C.</given-names> <surname>Malenka</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Luo</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Tomer</surname></string-name> and <string-name><given-names>K.</given-names> <surname>Deisseroth</surname></string-name> (<year>2015</year>). “<article-title>Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits</article-title>.” <source>Cell</source> <volume>162</volume>(<issue>3</issue>): <fpage>635</fpage>–<lpage>647</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>X.</given-names></string-name>, <string-name><given-names>S.-H.</given-names> <surname>Yeo</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>McQuillan</surname></string-name>, <string-name><given-names>M. K.</given-names> <surname>Herde</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hessler</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Cheong</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Porteous</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2021</year>). “<article-title>Highly redundant neuropeptide volume co-transmission underlying episodic activation of the GnRH neuron dendron</article-title>.” <source>eLife</source> <volume>10</volume>: <fpage>e62455</fpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Lizneva</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Suturina</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Walker</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Brakta</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Gavrilova-Jordan</surname></string-name> and <string-name><given-names>R.</given-names> <surname>Azziz</surname></string-name> (<year>2016</year>). “<article-title>Criteria, prevalence, and phenotypes of polycystic ovary syndrome</article-title>.” <source>Fertility and Sterility</source> <volume>106</volume>(<issue>1</issue>): <fpage>6</fpage>–<lpage>15</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>McCarthy</surname>, <given-names>E. A.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>Dischino</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Maguire</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Leon</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Talbi</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Cheung</surname></string-name>, <string-name><given-names>C. D.</given-names> <surname>Schteingart</surname></string-name>, <string-name><given-names>P. J. M.</given-names> <surname>Rivière</surname></string-name>, <string-name><given-names>S. D.</given-names> <surname>Reed</surname></string-name>, <string-name><given-names>R. A.</given-names> <surname>Steiner</surname></string-name> and <string-name><given-names>V. M.</given-names> <surname>Navarro</surname></string-name> (<year>2021</year>). “<article-title>Inhibiting Kiss1 Neurons With Kappa Opioid Receptor Agonists to Treat Polycystic Ovary Syndrome and Vasomotor Symptoms</article-title>.” <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>107</volume>(<issue>1</issue>): <fpage>e328</fpage>–<lpage>e347</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>McQuillan</surname>, <given-names>H. J.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Clarkson</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kauff</surname></string-name>, <string-name><given-names>S. Y.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>S. H.</given-names> <surname>Yip</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Cheong</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Porteous</surname></string-name>, <string-name><given-names>A. K.</given-names> <surname>Heather</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2022</year>). “<article-title>Definition of the estrogen negative feedback pathway controlling the GnRH pulse generator in female mice</article-title>.” <source>Nature Communications</source> <volume>13</volume>(<issue>1</issue>): <fpage>7433</fpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>McQuillan</surname>, <given-names>H. J.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Clarkson</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kauff</surname></string-name>, <string-name><given-names>S. Y.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>S. H.</given-names> <surname>Yip</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Cheong</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Porteous</surname></string-name>, <string-name><given-names>A. K.</given-names> <surname>Heather</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2022</year>). “<article-title>Definition of the estrogen negative feedback pathway controlling the GnRH pulse generator in female mice</article-title>.” <source>Nat Commun</source> <volume>13</volume>(<issue>1</issue>): <fpage>7433</fpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>McQuillan</surname>, <given-names>H. J.</given-names></string-name>, <string-name><given-names>S. Y.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Cheong</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2019</year>). “<article-title>GnRH Pulse Generator Activity Across the Estrous Cycle of Female Mice</article-title>.” <source>Endocrinology</source> <volume>160</volume>(<issue>6</issue>): <fpage>1480</fpage>–<lpage>1491</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Moore</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>D. B.</given-names> <surname>Lohr</surname></string-name>, <string-name><given-names>L. M.</given-names> <surname>Coolen</surname></string-name> and <string-name><given-names>M. N.</given-names> <surname>Lehman</surname></string-name> (<year>2021</year>). “<article-title>Prenatal Androgen Exposure Alters KNDy Neurons and Their Afferent Network in a Model of Polycystic Ovarian Syndrome</article-title>.” <source>Endocrinology</source> <volume>162</volume>(<issue>11</issue>).</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Moore</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Prescott</surname></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2013</year>). “<article-title>Estradiol Negative and Positive Feedback in a Prenatal Androgen-Induced Mouse Model of Polycystic Ovarian Syndrome</article-title>.” <source>Endocrinology</source> <volume>154</volume>(<issue>2</issue>): <fpage>796</fpage>–<lpage>806</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Moore</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Prescott</surname></string-name>, <string-name><given-names>C. J.</given-names> <surname>Marshall</surname></string-name>, <string-name><given-names>S. H.</given-names> <surname>Yip</surname></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2015</year>). “<article-title>Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome</article-title>.” <source>Proc Natl Acad Sci U S A</source> <volume>112</volume>(<issue>2</issue>): <fpage>596</fpage>–<lpage>601</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Morales</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Laughlin</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Bützow</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Maheshwari</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Baumann</surname></string-name> and <string-name><given-names>S.</given-names> <surname>Yen</surname></string-name> (<year>1996</year>). “<article-title>Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features</article-title>.” <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>81</volume>(<issue>8</issue>): <fpage>2854</fpage>–<lpage>2864</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Morales</surname>, <given-names>A. J.</given-names></string-name>, <string-name><given-names>G. A.</given-names> <surname>Laughlin</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Bützow</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Maheshwari</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Baumann</surname></string-name> and <string-name><given-names>S. S.</given-names> <surname>Yen</surname></string-name> (<year>1996</year>). “<article-title>Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features</article-title>.” <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>81</volume>(<issue>8</issue>): <fpage>2854</fpage>–<lpage>2864</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Morris</surname>, <given-names>P. G.</given-names></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2023</year>). “<article-title>Mechanism of Arcuate Kisspeptin Neuron Synchronization in Acute Brain Slices From Female Mice</article-title>.” <source>Endocrinology</source> <volume>164</volume>(<fpage>12</fpage>).</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Navarro</surname>, <given-names>V. M.</given-names></string-name>, <string-name><given-names>M. L.</given-names> <surname>Gottsch</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Chavkin</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Okamura</surname></string-name>, <string-name><given-names>D. K.</given-names> <surname>Clifton</surname></string-name> and <string-name><given-names>R. A.</given-names> <surname>Steiner</surname></string-name> (<year>2009</year>). “<article-title>Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse</article-title>.” <source>J Neurosci</source> <volume>29</volume>(<issue>38</issue>): <fpage>11859</fpage>–<lpage>11866</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Nestler</surname>, <given-names>J. E.</given-names></string-name> and <string-name><given-names>D. J.</given-names> <surname>Jakubowicz</surname></string-name> (<year>1997</year>). “<article-title>Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens</article-title>.” <source>J Clin Endocrinol Metab</source> <volume>82</volume>(<issue>12</issue>): <fpage>4075</fpage>–<lpage>4079</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Osuka</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Iwase</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Nakahara</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kondo</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Saito</surname></string-name>, <string-name><surname>Bayasula</surname>, <given-names>T.</given-names></string-name> <string-name><surname>Nakamura</surname>, <given-names>S.</given-names></string-name> <string-name><surname>Takikawa</surname>, <given-names>M.</given-names></string-name> <string-name><surname>Goto</surname>, <given-names>T.</given-names></string-name> <string-name><surname>Kotani</surname> and <given-names>F.</given-names></string-name> <string-name><surname>Kikkawa</surname></string-name> (<year>2016</year>). “<article-title>Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome</article-title>.” <source>Endocrinology</source> <volume>158</volume>(<issue>2</issue>): <fpage>367</fpage>–<lpage>377</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Pastor</surname>, <given-names>C. L.</given-names></string-name>, <string-name><given-names>M. L.</given-names> <surname>Griffin-Korf</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Aloi</surname></string-name>, <string-name><given-names>W. S.</given-names> <surname>Evans</surname></string-name> and <string-name><given-names>J. C.</given-names> <surname>Marshall</surname></string-name> (<year>1998</year>). “<article-title>Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone1</article-title>.” <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>83</volume>(<issue>2</issue>): <fpage>582</fpage>–<lpage>590</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Patel</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>M. S.</given-names> <surname>Coffler</surname></string-name>, <string-name><given-names>M. H.</given-names> <surname>Dahan</surname></string-name>, <string-name><given-names>R. Y.</given-names> <surname>Yoo</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Lawson</surname></string-name>, <string-name><given-names>P. J.</given-names> <surname>Malcom</surname></string-name> and <string-name><given-names>R. J.</given-names> <surname>Chang</surname></string-name> (<year>2003</year>). “<article-title>Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion</article-title>.” <source>J Clin Endocrinol Metab</source> <volume>88</volume>(<issue>11</issue>): <fpage>5456</fpage>–<lpage>5461</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Phylactou</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>S. A.</given-names> <surname>Clarke</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Patel</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Baggaley</surname></string-name>, <string-name><given-names>C. N.</given-names> <surname>Jayasena</surname></string-name>, <string-name><given-names>T. W.</given-names> <surname>Kelsey</surname></string-name>, <string-name><given-names>A. N.</given-names> <surname>Comninos</surname></string-name>, <string-name><given-names>W. S.</given-names> <surname>Dhillo</surname></string-name> and <string-name><given-names>A.</given-names> <surname>Abbara</surname></string-name> (<year>2021</year>). “<article-title>Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS)</article-title>.” <source>Clinical Endocrinology</source> <volume>95</volume>(<issue>2</issue>): <fpage>239</fpage>–<lpage>252</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Porteous</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>P.</given-names> <surname>Haden</surname></string-name>, <string-name><given-names>E. C. R.</given-names> <surname>Hackwell</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Singline</surname></string-name>, <string-name><given-names>M. K.</given-names> <surname>Herde</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Desai</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name>, <string-name><given-names>D. R.</given-names> <surname>Grattan</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2021</year>). “<article-title>Reformulation of PULSAR for Analysis of Pulsatile LH Secretion and a Revised Model of Estrogen-Negative Feedback in Mice</article-title>.” <source>Endocrinology</source> <volume>162</volume>(<issue>11</issue>).</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Qiu</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>C. C.</given-names> <surname>Nestor</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Padilla</surname></string-name>, <string-name><given-names>R. D.</given-names> <surname>Palmiter</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>Kelly</surname></string-name> and <string-name><given-names>O. K.</given-names> <surname>Rønnekleiv</surname></string-name> (<year>2016</year>). “<article-title>High-frequency stimulation-induced peptide release synchronizes arcuate kisspeptin neurons and excites GnRH neurons</article-title>.” <source>eLife</source> <volume>5</volume>: <fpage>e16246</fpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Risal</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Manti</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Fornes</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Larsson</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Benrick</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Deng</surname></string-name>, <string-name><given-names>C. E.</given-names> <surname>Cesta</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Rosenqvist</surname></string-name> and <string-name><given-names>E.</given-names> <surname>Stener-Victorin</surname></string-name> (<year>2021</year>). “<article-title>Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders</article-title>.” <source>Translational Psychiatry</source> <volume>11</volume>(<issue>1</issue>): <fpage>45</fpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Rodriguez Paris</surname>, <given-names>V.</given-names></string-name> and <string-name><given-names>M. J.</given-names> <surname>Bertoldo</surname></string-name> (<year>2019</year>). “<article-title>The Mechanism of Androgen Actions in PCOS Etiology</article-title>.” <source>Medical Sciences</source> <volume>7</volume>(<issue>9</issue>): <fpage>89</fpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Roland</surname>, <given-names>A. V.</given-names></string-name> and <string-name><given-names>S. M.</given-names> <surname>Moenter</surname></string-name> (<year>2011</year>). “<article-title>Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood</article-title>.” <source>Endocrinology</source> <volume>152</volume>(<issue>2</issue>): <fpage>618</fpage>–<lpage>628</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Ruddenklau</surname>, <given-names>A.</given-names></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2019</year>). “<article-title>Neuroendocrine Impairments of Polycystic Ovary Syndrome</article-title>.” <source>Endocrinology</source> <volume>160</volume>(<issue>10</issue>): <fpage>2230</fpage>–<lpage>2242</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Silva</surname>, <given-names>M. S.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Prescott</surname></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2018</year>). “<article-title>Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS</article-title>.” <source>JCI Insight</source> <volume>3</volume>(<issue>7</issue>).</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Silva</surname>, <given-names>M. S. B.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Desroziers</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hessler</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Prescott</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Coyle</surname></string-name>, <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2019</year>). “<article-title>Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction: Implications for polycystic ovary syndrome</article-title>.” <source>EBioMedicine</source> <volume>44</volume>: <fpage>582</fpage>–<lpage>596</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>O’Neill</surname></string-name> and <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name> (<year>1995</year>). “<article-title>Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice</article-title>.” <source>Endocrinology</source> <volume>136</volume>(<issue>12</issue>): <fpage>5311</fpage>–<lpage>5321</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Stener-Victorin</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>V.</given-names> <surname>Padmanabhan</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Walters</surname></string-name>, <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Benrick</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Giacobini</surname></string-name>, <string-name><given-names>D. A.</given-names> <surname>Dumesic</surname></string-name> and <string-name><given-names>D. H.</given-names> <surname>Abbott</surname></string-name> (<year>2020</year>). “<article-title>Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome</article-title>.” <source>Endocr Rev</source> <volume>41</volume>(<issue>4</issue>).</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Steyn</surname>, <given-names>F. J.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Wan</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Clarkson</surname></string-name>, <string-name><given-names>J. D.</given-names> <surname>Veldhuis</surname></string-name>, <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> and <string-name><given-names>C.</given-names> <surname>Chen</surname></string-name> (<year>2013</year>). “<article-title>Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice</article-title>.” <source>Endocrinology</source> <volume>154</volume>(<issue>12</issue>): <fpage>4939</fpage>–<lpage>4945</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Sullivan</surname>, <given-names>S. D.</given-names></string-name> and <string-name><given-names>S. M.</given-names> <surname>Moenter</surname></string-name> (<year>2004</year>). “<article-title>Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder</article-title>.” <source>Proc Natl Acad Sci U S A</source> <volume>101</volume>(<issue>18</issue>): <fpage>7129</fpage>–<lpage>7134</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Taylor</surname>, <given-names>A. E.</given-names></string-name>, <string-name><given-names>B.</given-names> <surname>McCourt</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Martin</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Anderson</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Adams</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Schoenfeld</surname></string-name> and <string-name><given-names>J. E.</given-names> <surname>Hall</surname></string-name> (<year>1997</year>). “<article-title>Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome</article-title>.” <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>82</volume>(<issue>7</issue>): <fpage>2248</fpage>–<lpage>2256</lpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><collab>The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group</collab> (<year>2004</year>). “<article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)</article-title>.” <source>Human Reproduction</source> <volume>19</volume>(<issue>1</issue>): <fpage>41</fpage>–<lpage>47</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Toosy</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Sodi</surname></string-name> and <string-name><given-names>J. M.</given-names> <surname>Pappachan</surname></string-name> (<year>2018</year>). “<article-title>Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach</article-title>.” <source>J Diabetes Metab Disord</source> <volume>17</volume>(<issue>2</issue>): <fpage>277</fpage>–<lpage>285</lpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>van Houten</surname>, <given-names>E. L. A. F.</given-names></string-name>, <string-name><given-names>P.</given-names> <surname>Kramer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>McLuskey</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Karels</surname></string-name>, <string-name><given-names>A. P. N.</given-names> <surname>Themmen</surname></string-name> and <string-name><given-names>J. A.</given-names> <surname>Visser</surname></string-name> (<year>2012</year>). “<article-title>Reproductive and Metabolic Phenotype of a Mouse Model of PCOS</article-title>.” <source>Endocrinology</source> <volume>153</volume>(<issue>6</issue>): <fpage>2861</fpage>–<lpage>2869</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>Vas</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Wall</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Kalmar</surname></string-name>, <string-name><given-names>S. Y.</given-names> <surname>Han</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2024</year>). “<article-title>Long-term recordings of arcuate nucleus kisspeptin neurons across the mouse estrous cycle</article-title>.” <source>Endocrinology</source>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><string-name><surname>Waldstreicher</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>N. F.</given-names> <surname>Santoro</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Hall</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Filicori</surname></string-name> and <string-name><given-names>W. F.</given-names> <surname>Crowley</surname>, <suffix>Jr</suffix></string-name>. (<year>1988</year>). “<article-title>Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization</article-title>.” <source>J Clin Endocrinol Metab</source> <volume>66</volume>(<issue>1</issue>): <fpage>165</fpage>–<lpage>172</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>Wall</surname>, <given-names>E. G.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Desai</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Khant Aung</surname></string-name>, <string-name><given-names>S. H.</given-names> <surname>Yeo</surname></string-name>, <string-name><given-names>D. R.</given-names> <surname>Grattan</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name> and <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> (<year>2023</year>). “<article-title>Unexpected Plasma Gonadal Steroid and Prolactin Levels Across the Mouse Estrous Cycle</article-title>.” <source>Endocrinology</source> <volume>164</volume>(<issue>6</issue>).</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Walters</surname>, <given-names>K. A.</given-names></string-name>, <string-name><given-names>R. B.</given-names> <surname>Gilchrist</surname></string-name>, <string-name><given-names>W. L.</given-names> <surname>Ledger</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>Teede</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Handelsman</surname></string-name> and <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> (<year>2018</year>). “<article-title>New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins</article-title>.” <source>Trends in Endocrinology &amp; Metabolism</source> <volume>29</volume>(<issue>12</issue>): <fpage>841</fpage>–<lpage>852</lpage>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>W.</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Shen</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Yeo</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Long</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Lyu</surname></string-name>, <string-name><given-names>A. E.</given-names> <surname>Herbison</surname></string-name> and <string-name><given-names>Y.</given-names> <surname>Kuang</surname></string-name> (<year>2020</year>). “<article-title>Different dendritic domains of the GnRH neuron underlie the pulse and surge modes of GnRH secretion in female mice</article-title>.” <source>eLife</source> <volume>9</volume>: <fpage>e53945</fpage>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Watanabe</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Fisher</surname></string-name>, <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name> and <string-name><given-names>C. L.</given-names> <surname>Jasoni</surname></string-name> (<year>2023</year>). “<article-title>Defining potential targets of prenatal androgen excess: Expression analysis of androgen receptor on hypothalamic neurons in the fetal female mouse brain</article-title>.” <source>Journal of Neuroendocrinology</source> <volume>35</volume>(<issue>6</issue>): <fpage>e13302</fpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Wierman</surname>, <given-names>M. E.</given-names></string-name>, <string-name><given-names>R. J.</given-names> <surname>Auchus</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Haisenleder</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Hall</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Handelsman</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hankinson</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Rosner</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Singh</surname></string-name>, <string-name><given-names>P. M.</given-names> <surname>Sluss</surname></string-name> and <string-name><given-names>F. Z.</given-names> <surname>Stanczyk</surname></string-name> (<year>2014</year>). “<article-title>Editorial: The new instructions to authors for the reporting of steroid hormone measurements</article-title>.” <source>J Clin Endocrinol Metab</source> <volume>99</volume>(<issue>12</issue>): <fpage>4375</fpage>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><string-name><surname>Wildt</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Häusler</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Marshall</surname></string-name>, <string-name><given-names>J. S.</given-names> <surname>Hutchison</surname></string-name>, <string-name><given-names>T. M.</given-names> <surname>Plant</surname></string-name>, <string-name><given-names>P. E.</given-names> <surname>Belchetz</surname></string-name> and <string-name><given-names>E.</given-names> <surname>Knobil</surname></string-name> (<year>1981</year>). “<article-title>Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey</article-title>.” <source>Endocrinology</source> <volume>109</volume>(<issue>2</issue>): <fpage>376</fpage>–<lpage>385</lpage>.</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><string-name><surname>Wong</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>Ray</surname></string-name> and <string-name><given-names>D. A.</given-names> <surname>Kendall</surname></string-name> (<year>2012</year>). “<article-title>Progesterone pharmacokinetics in the mouse: implications for potential stroke therapy</article-title>.” <source>Journal of Pharmacy and Pharmacology</source> <volume>64</volume>(<issue>11</issue>): <fpage>1614</fpage>–<lpage>1620</lpage>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><string-name><surname>Yan</surname>, <given-names>X.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Yuan</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Cui</surname></string-name> and <string-name><given-names>J.</given-names> <surname>Liu</surname></string-name> (<year>2014</year>). “<article-title>Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats</article-title>.” <source>Journal of Endocrinology</source> <volume>222</volume>(<issue>1</issue>): <fpage>73</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><string-name><surname>Yeo</surname>, <given-names>S. H.</given-names></string-name>, <string-name><given-names>V.</given-names> <surname>Kyle</surname></string-name>, <string-name><given-names>P. G.</given-names> <surname>Morris</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Jackman</surname></string-name>, <string-name><given-names>L. C.</given-names> <surname>Sinnett-Smith</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Schacker</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Chen</surname></string-name> and <string-name><given-names>W. H.</given-names> <surname>Colledge</surname></string-name> (<year>2016</year>). “<article-title>Visualisation of Kiss1 Neurone Distribution Using a Kiss1-CRE Transgenic Mouse</article-title>.” <source>J Neuroendocrinol</source> <volume>28</volume>(<issue>11</issue>).</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.97179.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Wei</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Washington State University</institution>
</institution-wrap>
<city>Pullman</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study reports findings on the GnRH pulse generator's role in androgen-exposed mouse models, providing further insights into PCOS pathophysiology and advancing the field of reproductive endocrinology. The experimental data were collected using cutting-edge methodologies and were <bold>solid</bold>. However, it is noteworthy that the findings, while interesting, are primarily applicable to mouse models, and their translation to human physiology requires cautious interpretation and further validation. This work will be of interest to endocrinologists and reproductive biologists.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.97179.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The manuscript involves 11 research vignettes that interrogate key aspects of GnRH pulse generator in two established mouse models of PCOS (peripubertal and prenatal androgenisation; PPA and PNA) (9 of the vignettes focus on the latter model).</p>
<p>A key message of this paper is that the oft-quoted idea of rapid GnRH/LH pulses associated with PCOS is in fact not readily demonstrable in PNA and PPA mice. This is an important message to make known, but when established dogmas are being challenged, the experiments behind them need to be robust. In this case, underpowered experiments and one or two other issues greatly limit the overall robustness of the study.</p>
<p>General critiques</p>
<p>(1) My main concern is that many/most of the experiments were limited to 4-5 mice per group (PPA experiments 1 and 2, PNA experiments 3, 5, 6, 8, and 9). This seems very underpowered for trying to disprove established dogmas (sometimes falling back on &quot;non-significant trends&quot; - lines 105 and 239).</p>
<p>(2) Page 133-142: it is concerning that the PNA mice didn't have elevated testosterone levels, and this clearly isn't the fault of the assay as this was re-tested in the laboratory of Prof Handelsman, an expert in the field, using LCMS. The point (clearly made in lines 315-336 of the Discussion) that elevated testosterone in PNA mice has been shown in some but not other publications is an important concern to describe for the field. However, the fact remains that it IS elevated in numerous studies, and in the current study it is not so, yet the authors go on to present GnRH pulse generator data as characteristic of the PNA model. Perhaps a demonstration of elevated testosterone levels (by LCMS?) should become a standard model validation prerequisite for publishing any PNA model data.</p>
<p>(3) Line 191-196: the lack of a significant increase in LH pulse frequency in PNA mice is based on measurements using reasonable group sizes (7-8), although the sampling frequency is low for this type of analysis (10-minute intervals; 6-minute intervals would seem safer for not missing some pulses). The significance of the LH pulse frequency results is not stated (looks like about p=0.01). The authors note that LH concentration IS elevated (approximately doubled), and this clearly is not caused by an increase in amplitude (Figure 4 G, H, I). These things are worth commenting on in the discussion.</p>
<p>(4) An interesting observation is that PNA mice appear to continue to have cyclical patterns of GnRH pulse generator activity despite reproductive acyclicity as determined by vaginal cytology (lines 209-241). This finding was used to analyse the frequency of GnRH pulse generator SEs in the machine-learning-identified diestrous-like stage of PNA mice and compare it to diestrous control mice (as identified by vaginal cytology?) (lines 245-254). The idea of a cycle stage-specific comparison is good, but surely the only valid comparison would be to use machine-learning to identify the diestrous-like stage in both groups of mice. Why use machine learning for one and vaginal cytology for the other?</p>
<p>Specific points</p>
<p>(5) With regard to point 2 above, it would be helpful to note the age at which the testosterone samples were taken.</p>
<p>(6) Lines 198-205 and 258-266: I think these are repeated measures of ANOVA data? If so, report the main relevant effect before the post hoc test result.</p>
<p>(7) Line 415: I don't think the word &quot;although&quot; works in this sentence.</p>
<p>(8) Lines 514-518: what are the limits of hormone detection in the LCMS assay?</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.97179.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary</p>
<p>The authors aimed to investigate the functionality of the GnRH (gonadotropin-releasing hormone) pulse generator in different mouse models to understand its role in reproductive physiology and its implications for conditions like polycystic ovary syndrome (PCOS). They compared the GnRH pulse generator activity in control mice, peripubertal androgen (PPA) treated mice, and prenatal androgen (PNA) exposed mice. The study sought to elucidate how androgen exposure affects the GnRH pulse generator and subsequent LH (luteinizing hormone) secretion, contributing to the pathophysiology of PCOS.</p>
<p>Strengths</p>
<p>(1) Comprehensive Model Selection: The use of both PPA and PNA mouse models allows for a comparative analysis that can distinguish the effects of different timings of androgen exposure.</p>
<p>(2) Detailed Methodology: The methods employed, such as photometry recordings and serial blood sampling, are robust and allow for precise measurement of GnRH pulse generator activity and LH secretion.</p>
<p>(3) Clear Results Presentation: The experimental results are well-documented with appropriate statistical analyses, ensuring the findings are reliable and reproducible.</p>
<p>(4) Relevance to PCOS: The study addresses a significant gap in understanding the neuroendocrine mechanisms underlying PCOS, making the findings relevant to both basic science and potentially clinical research.</p>
<p>Weaknesses</p>
<p>(1) Model Limitations: While the PNA mouse model is suggested as the most appropriate for studying PCOS, the authors acknowledge that it does not completely replicate the human condition, particularly the elevated LH response seen in women with PCOS.</p>
<p>(2) Complex Data Interpretation: The reduced progesterone feedback and its effects on the GnRH pulse generator in PNA mice add complexity to data interpretation, making it challenging to draw straightforward conclusions.</p>
<p>(3) Machine Learning (ML) Selection and Validation: While k-means clustering is a useful tool for pattern recognition, the manuscript lacks detailed justification for choosing this specific algorithm over other potential methods. The robustness of clustering results has not been validated.</p>
<p>(4) Biological Interpretability: Although the machine learning approach identified cyclical patterns, the biological interpretation of these clusters in the context of PCOS is not thoroughly discussed. A deeper exploration of how these clusters correlate with physiological and pathological states could enhance the study's impact.</p>
<p>(5) Sample Size: The study uses a relatively small number of animals (n=4-7 per group), which may limit the generalisability of the findings. Larger sample sizes could provide more robust and statistically significant results.</p>
<p>(6) Scope of Application: The findings, while interesting, are primarily applicable to mouse models. The translation to human physiology requires cautious interpretation and further validation.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.97179.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Zhou and colleagues elegantly used pre-clinical mouse models to understand the nature of abnormally high GnRH/LH pulse secretion in polycystic ovary syndrome (PCOS), a major endocrine disorder affecting female fertility worldwide. This work brings a fundamental question of how altered gonadotropin secretion takes place upstream within the GnRH pulse generator core, which is defined by arcuate nucleus kisspeptin neurons.</p>
<p>Strengths:</p>
<p>The authors use state-of-the-art in vivo calcium imaging with fiber photometry and important physiological manipulations and measurements to dissect the possible neuronal mechanisms underlying such neuroendocrine derangements in PCOS. The additional use of unsupervised k-means clustering analysis for the evaluation of calcium synchronous events greatly enhances the quality of their evidence. The authors nicely propose that neuroendocrine dysfunction in PCOS might involve different setpoints through the hypothalamic-pituitary-gonadal (HPG) axis, and beyond kisspeptin neurons, which importantly pushes our field forward toward future investigations.</p>
<p>Weaknesses:</p>
<p>Although the authors provide important evidence, additional efforts are required to improve the quality of the manuscript and back up their claims. For instance, animal experiments failed to detect high testosterone levels in PNA female mice, a well-established PCOS mouse model. Considering that androgen excess is a hallmark of PCOS, this highly influences the subsequent evaluation of calcium synchronous events in arcuate kisspeptin neurons and the implications for neuroendocrine derangements. Authors also may need to provide LH data from another mouse model used in their work, the peripubertal androgen (PPA) model. Their claims seem to fall short without the pairing evidence of calcium synchronous events in arcuate kisspeptin neurons and LH pulse secretion. Another aspect that requires reviewing, is further exploration of their calcium synchronous events data and the increase of animal numbers in some of their experiments.</p>
</body>
</sub-article>
</article>